| 1 |
Liu Y, Xu H, Yan N, Tang Z, Wang Q. Research progress of ophthalmic preparations of immunosuppressants. Drug Deliv 2023;30:2175925. [PMID: 36762580 DOI: 10.1080/10717544.2023.2175925] [Reference Citation Analysis]
|
| 2 |
Lv B, Liu L, Liu X, Huang M, Chen X, Tang K, Wang C, Chen P. Incidence, clinical features and risk factors of tacrolimus induced idiosyncratic liver injury in renal transplant recipients: A nested case-control study. Front Pharmacol 2023;14. [DOI: 10.3389/fphar.2023.1126765] [Reference Citation Analysis]
|
| 3 |
McDaniels JM, Shetty AC, Kuscu C, Kuscu C, Bardhi E, Rousselle T, Drachenberg C, Talwar M, Eason JD, Muthukumar T, Maluf DG, Mas VR. Single nuclei transcriptomics delineates complex immune and kidney cell interactions contributing to kidney allograft fibrosis. Kidney Int 2023:S0085-2538(23)00142-4. [PMID: 36863444 DOI: 10.1016/j.kint.2023.02.018] [Reference Citation Analysis]
|
| 4 |
Yakubu I, Moinuddin I, Gupta G. Use of belatacept in kidney transplantation: what's new? Curr Opin Organ Transplant 2023;28:36-45. [PMID: 36326538 DOI: 10.1097/MOT.0000000000001033] [Reference Citation Analysis]
|
| 5 |
Yang D, Wang Y, Zhuang B, Xu M, Wang C, Xie X, Huang G, Zheng Y, Xie X. Nomogram based on high-frequency shear wave elastography (SWE) to evaluate chronic changes after kidney transplantation. Eur Radiol 2023;33:763-73. [PMID: 36064980 DOI: 10.1007/s00330-022-09054-1] [Reference Citation Analysis]
|
| 6 |
Moein M, Papa S, Ortiz N, Saidi R. Protocol Biopsy After Kidney Transplant: Clinical Application and Efficacy to Detect Allograft Rejection. Cureus 2023;15:e34505. [PMID: 36874304 DOI: 10.7759/cureus.34505] [Reference Citation Analysis]
|
| 7 |
Lopez-Soler RI, Nikouee A, Kim M, Khan S, Sivaraman L, Ding X, Zang QS. Beclin-1 dependent autophagy improves renal outcomes following Unilateral Ureteral Obstruction (UUO) injury. Front Immunol 2023;14:1104652. [PMID: 36875088 DOI: 10.3389/fimmu.2023.1104652] [Reference Citation Analysis]
|
| 8 |
Huang X, Nie F, Zhu J, Liu L, Wang N. Application value of shear-wave elastography combined with monochrome superb microvascular imaging in renal allograft chronic rejection. Clin Hemorheol Microcirc 2022;82:303-11. [PMID: 36057814 DOI: 10.3233/CH-221443] [Reference Citation Analysis]
|
| 9 |
Tawhari I, Hallak P, Bin S, Yamani F, Safar-Boueri M, Irshad A, Leventhal J, Ansari MJ, Cravedi P, Gallon L. Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients. Front Immunol 2022;13:1096881. [PMID: 36601111 DOI: 10.3389/fimmu.2022.1096881] [Reference Citation Analysis]
|
| 10 |
Sallaberger S, Buchwinkler L, Eder S, Schneeberger S, Mayer G, Pirklbauer M. Population Characteristics and Clinical Outcomes from the Renal Transplant Outcome Prediction Validation Study (TOPVAS). J Clin Med 2022;11. [PMID: 36556037 DOI: 10.3390/jcm11247421] [Reference Citation Analysis]
|
| 11 |
Chapman JR. From the Wright Brothers to the A380: Developing Transplantation Takes Teams of Teams. Transplantation 2022;106:2281-3. [PMID: 36436098 DOI: 10.1097/TP.0000000000004450] [Reference Citation Analysis]
|
| 12 |
Wong G, Pleass H, O'Connell P, Nankivell B, Allen R, Craig JC; Westmead Transplant and Research Unit. "Creating Blue Skies Overhead for All" Introduction of the 2022 Recipient of the Medawar Prize of the Transplantation Society: Professor Jeremy Chapman. Transplantation 2022;106:2284-5. [PMID: 36436099 DOI: 10.1097/TP.0000000000004449] [Reference Citation Analysis]
|
| 13 |
Bredewold OW, Chan J, Svensson M, Bruchfeld A, de Fijter JW, Furuland H, Grinyo JM, Hartmann A, Holdaas H, Hellberg O, Jardine A, Mjörnstedt L, Skov K, Smerud KT, Soveri I, Sørensen SS, Zonneveld AV, Fellström B. Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial. Kidney Med 2023;5:100574. [PMID: 36593877 DOI: 10.1016/j.xkme.2022.100574] [Reference Citation Analysis]
|
| 14 |
Mathur V, Reaven NL, Funk SE, Tangri N. Serum Bicarbonate and Graft and Patient Outcomes Among Kidney Transplant Recipients: A Retrospective Cohort Study Evaluating Changes in Serum Bicarbonate Over Time. Kidney Med 2023;5:100573. [PMID: 36683962 DOI: 10.1016/j.xkme.2022.100573] [Reference Citation Analysis]
|
| 15 |
Hernández D, Vázquez-sánchez T, Sola E, Lopez V, Ruiz-esteban P, Caballero A, Salido E, Leon M, Rodriguez A, Serra N, Rodriguez C, Facundo C, Perello M, Silva I, Marrero-miranda D, Cidraque I, Moreso F, Guirado L, Serón D, Torres A. Treatment of early borderline lesions in low immunological risk kidney transplant patients: a Spanish multicenter, randomized, controlled parallel-group study protocol: the TRAINING study. BMC Nephrol 2022;23:357. [DOI: 10.1186/s12882-022-02989-z] [Reference Citation Analysis]
|
| 16 |
Vaulet T, Divard G, Thaunat O, Koshy P, Lerut E, Senev A, Aubert O, Van Loon E, Callemeyn J, Emonds MP, Van Craenenbroeck A, De Vusser K, Sprangers B, Rabeyrin M, Dubois V, Kuypers D, De Vos M, Loupy A, De Moor B, Naesens M. Data-Driven Chronic Allograft Phenotypes: A Novel and Validated Complement for Histologic Assessment of Kidney Transplant Biopsies. J Am Soc Nephrol 2022;33:2026-39. [PMID: 36316096 DOI: 10.1681/ASN.2022030290] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 17 |
Loga L, Dican L, Matei HV, Mărunțelu I, Constantinescu I. Relevant biomarkers of kidney allograft rejection. J Med Life 2022;15:1330-3. [PMID: 36567832 DOI: 10.25122/jml-2022-0181] [Reference Citation Analysis]
|
| 18 |
Kaufmann YL, von Moos S, Spitznagel T, Matter LS, Mueller TF, Schachtner T. Collaboration between local nephrologists and the transplant centre ensures good outcomes in post-transplant care. Clin Kidney J 2023;16:331-41. [PMID: 36755830 DOI: 10.1093/ckj/sfac232] [Reference Citation Analysis]
|
| 19 |
Teixeira AC, Távora F, Mourão EA, Castaldelli GB, Evangelista TBAB, de Matos Esmeraldo R, de Sandes-Freitas TV. The Immunohistochemical Expression of the Von Willebrand Factor: A Potential Tool to Predict Kidney Allograft Outcomes. Appl Immunohistochem Mol Morphol 2022. [PMID: 36251974 DOI: 10.1097/PAI.0000000000001078] [Reference Citation Analysis]
|
| 20 |
Rendina M, Paoletti E, Labarile N, Marra A, Iannone A, Castellaneta A, Bussalino E, Ravera M, Schena A, Castellaneta NM, Barone M, Simone S, Gesualdo L, Di Leo A. HCV-positive kidney transplant patients treated with direct-acting antivirals maintain stable medium-term graft function despite persistent reduction in tacrolimus trough levels. Ther Adv Chronic Dis 2022;13:20406223221117975. [PMID: 36147292 DOI: 10.1177/20406223221117975] [Reference Citation Analysis]
|
| 21 |
Zapata CM, Ibrahim HN. Kidney Disease after Heart and Lung Transplantation. Methodist Debakey Cardiovasc J 2022;18:34-40. [PMID: 36132582 DOI: 10.14797/mdcvj.1122] [Reference Citation Analysis]
|
| 22 |
Buyukdemirci S, Oguz EG, Cimen SG, Sahin H, Cimen S, Ayli MD. Vitamin D deficiency may predispose patients to increased risk of kidney transplant rejection. World J Transplant 2022; 12(9): 299-309 [DOI: 10.5500/wjt.v12.i9.299] [Reference Citation Analysis]
|
| 23 |
Itabashi Y, Ravichandran R, Bansal S, Chin C, Poulson C, Sureshbabu A, Nair SS, Perincheri S, Mohanakumar T. Role for exosomes with self-antigens and immune regulatory molecules in allo- and auto-immunity leading to chronic immune injury following murine kidney transplantation. Transpl Immunol 2022;75:101702. [PMID: 36038048 DOI: 10.1016/j.trim.2022.101702] [Reference Citation Analysis]
|
| 24 |
Friedl S, Jung EM, Bergler T, Tews HC, Banas MC, Banas B, Putz FJ. Factors influencing the time-intensity curve analysis of contrast-enhanced ultrasound in kidney transplanted patients: Toward a standardized contrast-enhanced ultrasound examination. Front Med 2022;9. [DOI: 10.3389/fmed.2022.928567] [Reference Citation Analysis]
|
| 25 |
Hilburger CE, Rosenwasser MJ, Delcassian D. The type 1 diabetes immune niche: Immunomodulatory biomaterial design considerations for beta cell transplant therapies. Journal of Immunology and Regenerative Medicine 2022;17:100063. [DOI: 10.1016/j.regen.2022.100063] [Reference Citation Analysis]
|
| 26 |
Ponticelli C, Citterio F. Non-Immunologic Causes of Late Death-Censored Kidney Graft Failure: A Personalized Approach. JPM 2022;12:1271. [DOI: 10.3390/jpm12081271] [Reference Citation Analysis]
|
| 27 |
Zheng X, Zhang W, Zhou H, Cao R, Shou Z, Zhang S, Cheng Y, Chen X, Ding C, Tang Z, Li N, Shi S, Zhou Q, Chen Q, Chen G, Chen Z, Zhou P, Hu X, Zhang X, Na N, Wang W. A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients. Chin Med J (Engl) 2022. [PMID: 35861301 DOI: 10.1097/CM9.0000000000001866] [Reference Citation Analysis]
|
| 28 |
Zamir MR, Shahi A, Salehi S, Amirzargar A. Natural killer cells and killer cell immunoglobulin-like receptors in solid organ transplantation: Protectors or opponents? Transplantation Reviews 2022. [DOI: 10.1016/j.trre.2022.100723] [Reference Citation Analysis]
|
| 29 |
Letellier T, Kervella D, Sadek A, Masset C, Garandeau C, Fourgeux C, Gourain V, Poschmann J, Blancho G, Ville S; on behalf of the Divat Consortium. Time-Limited Therapy with Belatacept in Kidney Transplant Recipients. JCM 2022;11:3229. [DOI: 10.3390/jcm11113229] [Reference Citation Analysis]
|
| 30 |
Betjes MGH, Roelen DL, van Agteren M, Kal-van Gestel J. Causes of Kidney Graft Failure in a Cohort of Recipients With a Very Long-Time Follow-Up After Transplantation. Front Med 2022;9:842419. [DOI: 10.3389/fmed.2022.842419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 31 |
Park J, Jung BH. Future-directed studies on immunosuppressive treatments and xenografts for organ transplantation. Ann Liver Transplant 2022;2:1-7. [DOI: 10.52604/alt.22.0003] [Reference Citation Analysis]
|
| 32 |
Morel A, Hoisnard L, Dudreuilh C, Moktefi A, Kheav D, Pimentel A, Sakhi H, Mokrani D, Attias P, El Sakhawi K, Champy CM, Remy P, Sbidian E, Grimbert P, Matignon M. Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy. Transpl Int 2022;35:10228. [PMID: 35497889 DOI: 10.3389/ti.2022.10228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 33 |
Silva R, Nascimento E, Lasmar M, Fabreti-oliveira R. Outcomes and Allograft Survival of Patients Who Underwent a Second Kidney Transplant and Were Followed Up for 10 Years. Transplantation Proceedings 2022. [DOI: 10.1016/j.transproceed.2022.04.006] [Reference Citation Analysis]
|
| 34 |
Arnold M, Steffen U, Wiesener M, Bach C, Spriewald BM, Lindemann M. Correlation of Anti-HLA IgA Alloantibodies and Fc Receptor Motives with Kidney Allograft Survival. Immuno 2022;2:372-86. [DOI: 10.3390/immuno2020023] [Reference Citation Analysis]
|
| 35 |
Brilland B, Laplante P, Thebault P, Geoffroy K, Brissette MJ, Latour M, Chassé M, Qi S, Hébert MJ, Cardinal H, Cailhier JF. MFG-E8 Reduces Aortic Intimal Proliferation in a Murine Model of Transplant Vasculopathy. Int J Mol Sci 2022;23. [PMID: 35456911 DOI: 10.3390/ijms23084094] [Reference Citation Analysis]
|
| 36 |
Lassen E, Daehn IS. Hypertrophy and glomerular cell adaptation through crosstalk leads to glomerular injury after kidney transplantation. Kidney International 2022;101:673-6. [DOI: 10.1016/j.kint.2022.01.008] [Reference Citation Analysis]
|
| 37 |
Jouve T, Noble J, Naciri-bennani H, Dard C, Masson D, Fiard G, Malvezzi P, Rostaing L. Early Blood Transfusion After Kidney Transplantation Does Not Lead to dnDSA Development: The BloodIm Study. Front Immunol 2022;13:852079. [DOI: 10.3389/fimmu.2022.852079] [Reference Citation Analysis]
|
| 38 |
Shrestha P, Katta K, Talsma D, Naggi A, Hillebrands JL, van de Sluis B, van den Born J. Prevention of Triglyceridemia by (Non-)Anticoagulant Heparin(oids) Does Not Preclude Transplant Vasculopathy and Glomerulosclerosis. Front Cell Dev Biol 2022;10:798088. [PMID: 35345850 DOI: 10.3389/fcell.2022.798088] [Reference Citation Analysis]
|
| 39 |
Ho J, Okoli GN, Rabbani R, Lam OLT, Reddy VK, Askin N, Rampersad C, Trachtenberg A, Wiebe C, Nickerson P, Abou-Setta AM. Effectiveness of T cell-mediated rejection therapy: A systematic review and meta-analysis. Am J Transplant 2022;22:772-85. [PMID: 34860468 DOI: 10.1111/ajt.16907] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 40 |
Chan J, Svensson M, Tannæs TM, Waldum-Grevbo B, Jenssen T, Eide IA. Associations of Serum Uromodulin and Urinary Epidermal Growth Factor with Measured Glomerular Filtration Rate and Interstitial Fibrosis in Kidney Transplantation. Am J Nephrol 2022;53:108-17. [PMID: 35104815 DOI: 10.1159/000521757] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 41 |
Maple H, Charif R, Galliford J, Mclean A, Game D. Management of the Acute Transplant. Primer on Nephrology 2022. [DOI: 10.1007/978-3-030-76419-7_91] [Reference Citation Analysis]
|
| 42 |
Baker RJ, Daga SK. Long-Term Management of Kidney Transplant Recipients. Primer on Nephrology 2022. [DOI: 10.1007/978-3-030-76419-7_95] [Reference Citation Analysis]
|
| 43 |
Goebel J, Nathan JD, Defoor WR, Sheldon CA. Renal Transplantation. Pediatric Surgery 2022. [DOI: 10.1007/978-3-642-38482-0_135-1] [Reference Citation Analysis]
|
| 44 |
Chan J, Eide IA, Tannæs TM, Waldum-Grevbo B, Jenssen T, Svensson M. Marine n-3 Polyunsaturated Fatty Acids and Cellular Senescence Markers in Incident Kidney Transplant Recipients: The Omega-3 Fatty Acids in Renal Transplantation (ORENTRA) Randomized Clinical Trial. Kidney Med 2021;3:1041-9. [PMID: 34939013 DOI: 10.1016/j.xkme.2021.07.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 45 |
Lin J, Chen Y, Zhu H, Cheng K, Wang H, Yu X, Tang M, Chen J. Lymphatic Reconstruction in Kidney Allograft Aggravates Chronic Rejection by Promoting Alloantigen Presentation. Front Immunol 2021;12:796260. [PMID: 34956231 DOI: 10.3389/fimmu.2021.796260] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 46 |
Allred ET, Crane CR, Ingulli EG. Three-month protocol biopsies do not detect subclinical rejection in pediatric kidney transplant recipients at a single center. Transplantation Reports 2021;6:100082. [DOI: 10.1016/j.tpr.2021.100082] [Reference Citation Analysis]
|
| 47 |
Menon R, Otto EA, Berthier CC, Nair V, Farkash EA, Hodgin JB, Yang Y, Luo J, Woodside KJ, Zamani H, Norman SP, Wiggins RC, Kretzler M, Naik AS. Glomerular endothelial cell-podocyte stresses and crosstalk in structurally normal kidney transplants. Kidney International 2021. [DOI: 10.1016/j.kint.2021.11.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 48 |
Yap DY, Li PH, Tang C, So BY, Kwan LP, Chan GC, Lau CS, Chan TM. Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis. Kidney International Reports 2021. [DOI: 10.1016/j.ekir.2021.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 49 |
Shigematsu T, Tajima S, Fu R, Zhang M, Itoyama Y, Tsuchimoto A, Egashira N, Ieiri I. The mTOR inhibitor everolimus attenuates tacrolimus-induced renal interstitial fibrosis in rats. Life Sci 2021;288:120150. [PMID: 34793770 DOI: 10.1016/j.lfs.2021.120150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 50 |
Mejia C, Yadav A. Kidney Disease After Nonkidney Solid Organ Transplant. Adv Chronic Kidney Dis 2021;28:577-86. [PMID: 35367026 DOI: 10.1053/j.ackd.2021.10.010] [Reference Citation Analysis]
|
| 51 |
Naik AS, Wang SQ, Chowdhury M, Aqeel J, O'Connor CL, Wiggins JE, Bitzer M, Wiggins RC. Critical timing of ACEi initiation prevents compensatory glomerular hypertrophy in the remaining single kidney. Sci Rep 2021;11:19605. [PMID: 34599260 DOI: 10.1038/s41598-021-99124-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 52 |
Fadel FI, Abd Elbaky AMNE, Abdel Mawla MA, Moustafa WI, Saadi GE, Salah DM. Subclinical Rejection and Immunosuppression in Pediatric Kidney Transplant Recipients : Single Centre Study. Biomed Pharmacol J 2021;14:1149-1159. [DOI: 10.13005/bpj/2218] [Reference Citation Analysis]
|
| 53 |
Wei J, Chen L, Wang D, Tang L, Xie Z, Chen W, Zhang S, Weng G. Upregulation of RIP3 promotes necroptosis via a ROS‑dependent NF‑κB pathway to induce chronic inflammation in HK‑2 cells. Mol Med Rep 2021;24:783. [PMID: 34498705 DOI: 10.3892/mmr.2021.12423] [Reference Citation Analysis]
|
| 54 |
Noble J, Terrec F, Malvezzi P, Rostaing L. Adverse effects of immunosuppression after liver transplantation. Best Pract Res Clin Gastroenterol 2021;54-55:101762. [PMID: 34874845 DOI: 10.1016/j.bpg.2021.101762] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 55 |
Wang Y, Wang JY, Schnieke A, Fischer K. Advances in single-cell sequencing: insights from organ transplantation. Mil Med Res 2021;8:45. [PMID: 34389057 DOI: 10.1186/s40779-021-00336-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 56 |
Kwon Y, Lee KW, Kim YM, Park H, Jung MK, Choi YJ, Son JK, Hong J, Park SH, Kwon GY, Yoo H, Kim K, Kim SJ, Park JB, Shin EC. Expansion of CD45RA-FOXP3++ regulatory T cells is associated with immune tolerance in patients with combined kidney and bone marrow transplantation. Clin Transl Immunology 2021;10:e1325. [PMID: 34401148 DOI: 10.1002/cti2.1325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 57 |
Wyld MLR, Wyburn KR, Chadban SJ. Global Perspective on Kidney Transplantation: Australia. Kidney360 2021;2:1641-4. [PMID: 35372973 DOI: 10.34067/KID.0003692021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 58 |
Shen Q, Wang Y, Chen J, Ma L, Huang X, Tang SCW, Lan H, Jiang H, Chen J. Single-Cell RNA Sequencing Reveals the Immunological Profiles of Renal Allograft Rejection in Mice. Front Immunol 2021;12:693608. [PMID: 34367152 DOI: 10.3389/fimmu.2021.693608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 59 |
Codina S, Manonelles A, Tormo M, Sola A, Cruzado JM. Chronic Kidney Allograft Disease: New Concepts and Opportunities. Front Med (Lausanne) 2021;8:660334. [PMID: 34336878 DOI: 10.3389/fmed.2021.660334] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 60 |
Rodriguez-Niño A, Pastene DO, Post A, Said MY, Gomes-Neto AW, Kieneker LM, Heiner-Fokkema MR, Esatbeyoglu T, Rimbach G, Schnuelle P, Yard BA, Bakker SJL. Urinary Carnosinase-1 Excretion is Associated with Urinary Carnosine Depletion and Risk of Graft Failure in Kidney Transplant Recipients: Results of the TransplantLines Cohort Study. Antioxidants (Basel) 2021;10:1102. [PMID: 34356335 DOI: 10.3390/antiox10071102] [Reference Citation Analysis]
|
| 61 |
Wickramaratne N, Li R, Tian T, Khoraki J, Kang HS, Chmielewski C, Maitland J, Liebrecht LK, Fyffe-Freil R, Lindell SL, Mangino MJ. Cholangiocyte Epithelial to Mesenchymal Transition (EMT) is a potential molecular mechanism driving ischemic cholangiopathy in liver transplantation. PLoS One 2021;16:e0246978. [PMID: 34234356 DOI: 10.1371/journal.pone.0246978] [Reference Citation Analysis]
|
| 62 |
Wang Q, Li M, Cheng X, Xu G. Clinical efficacy and safety of different tacrolimus concentrations for the treatment of patients with idiopathic membranous nephropathy. Sci Rep 2021;11:13274. [PMID: 34168218 DOI: 10.1038/s41598-021-92678-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 63 |
Nguyen LT, Saad S, Shi Y, Wang R, Chou ASY, Gill A, Yao Y, Jarolimek W, Pollock CA. Lysyl oxidase inhibitors attenuate cyclosporin A-induced nephropathy in mouse. Sci Rep 2021;11:12437. [PMID: 34127702 DOI: 10.1038/s41598-021-91772-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 64 |
Mayrdorfer M, Liefeldt L, Wu K, Rudolph B, Zhang Q, Friedersdorff F, Lachmann N, Schmidt D, Osmanodja B, Naik MG, Duettmann W, Halleck F, Merkel M, Schrezenmeier E, Waiser J, Duerr M, Budde K. Exploring the Complexity of Death-Censored Kidney Allograft Failure. J Am Soc Nephrol 2021;32:1513-26. [PMID: 33883251 DOI: 10.1681/ASN.2020081215] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 19.5] [Reference Citation Analysis]
|
| 65 |
Zapke SE, Willmann S, Grebe SO, Menke K, Thürmann PA, Schmiedl S. Comparing Predictions of a PBPK Model for Cyclosporine With Drug Levels From Therapeutic Drug Monitoring. Front Pharmacol 2021;12:630904. [PMID: 34054518 DOI: 10.3389/fphar.2021.630904] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 66 |
Prezelin-Reydit M, Dubois V, Caillard S, Parissiadis A, Etienne I, Hau F, Albano L, Pourtein M, Barrou B, Taupin JL, Mariat C, Absi L, Vigneau C, Renac V, Guidicelli G, Visentin J, Merville P, Thaunat O, Couzi L. Prospective Measures of Adherence by Questionnaire, Low Immunosuppression and Graft Outcome in Kidney Transplantation. J Clin Med 2021;10:2032. [PMID: 34068497 DOI: 10.3390/jcm10092032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 67 |
Li ZH, An N, Huang XJ, Yang C, Wu HL, Chen XC, Pan QJ, Liu HF. Cyclosporine A blocks autophagic flux in tubular epithelial cells by impairing TFEB-mediated lysosomal function. J Cell Mol Med 2021;25:5729-43. [PMID: 33949118 DOI: 10.1111/jcmm.16593] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 68 |
Kirk AD, Adams AB, Durrbach A, Ford ML, Hildeman DA, Larsen CP, Vincenti F, Wojciechowski D, Woodle ES. Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients. Am J Transplant 2021;21:1691-8. [PMID: 33128812 DOI: 10.1111/ajt.16386] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 69 |
Ramazani Y, Knops N, Berlingerio SP, Adebayo OC, Lismont C, Kuypers DJ, Levtchenko E, van den Heuvel LP, Fransen M. Therapeutic concentrations of calcineurin inhibitors do not deregulate glutathione redox balance in human renal proximal tubule cells. PLoS One 2021;16:e0250996. [PMID: 33930094 DOI: 10.1371/journal.pone.0250996] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 70 |
Culos KA, Gatwood KS. Immunosuppressive agents and monitoring in long‐term survivors. Blood and Marrow Transplantation Long Term Management 2021. [DOI: 10.1002/9781119612780.ch37] [Reference Citation Analysis]
|
| 71 |
Chhajer G, Arunachalam VK, Ramasamy R, Mehta P, Cherian M. Elastography: a surrogate marker of renal allograft fibrosis - quantification by shear-wave technique. Pol J Radiol 2021;86:e151-6. [PMID: 33828625 DOI: 10.5114/pjr.2021.104582] [Reference Citation Analysis]
|
| 72 |
Infante B, Bellanti F, Correale M, Pontrelli P, Franzin R, Leo S, Calvaruso M, Mercuri S, Netti GS, Ranieri E, Brunetti ND, Grandaliano G, Gesualdo L, Serviddio G, Castellano G, Stallone G. mTOR inhibition improves mitochondria function/biogenesis and delays cardiovascular aging in kidney transplant recipients with chronic graft dysfunction. Aging (Albany NY) 2021;13:8026-39. [PMID: 33758105 DOI: 10.18632/aging.202863] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 73 |
Benjamens S, Antunes IF, Hillebrands JL, Reijrink M, Bulthuis MLC, Berger SP, Moers C, de Borst MH, Slart RHJA, Pol RA. [18F]-sodium fluoride autoradiography imaging of nephrocalcinosis in donor kidneys and explanted kidney allografts. Sci Rep 2021;11:1841. [PMID: 33469037 DOI: 10.1038/s41598-021-81144-4] [Reference Citation Analysis]
|
| 74 |
Demir ME, Merhametsiz Ö, Uyar M, Sevmi̇s M, Aktas S. Outcomes of mTORi-involving minimized immunosuppression protocols in renal transplantation. Journal of Health Sciences and Medicine 2021;4:71-77. [DOI: 10.32322/jhsm.835670] [Reference Citation Analysis]
|
| 75 |
Hoogduijn MJ, Issa F, Casiraghi F, Reinders MEJ. Cellular therapies in organ transplantation. Transpl Int 2021;34:233-44. [PMID: 33207013 DOI: 10.1111/tri.13789] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 76 |
Nishioka S, Ishimura T, Endo T, Yokoyama N, Ogawa S, Fujisawa M. Suppression of Allograft Fibrosis by Regulation of Mammalian Target of Rapamycin-Related Protein Expression in Kidney-Transplanted Recipients Treated with Everolimus and Reduced Tacrolimus. Ann Transplant 2021;26:e926476. [PMID: 33431785 DOI: 10.12659/AOT.926476] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 77 |
Grenier N, Gennisson J, Marcelin C, Le Bras Y, Couzi L. Elastography of the Kidney. Imaging in Nephrology 2021. [DOI: 10.1007/978-3-030-60794-4_19] [Reference Citation Analysis]
|
| 78 |
Brasile L. Repairing organs with MSC. Organ Repair and Regeneration 2021. [DOI: 10.1016/b978-0-12-819451-5.00005-6] [Reference Citation Analysis]
|
| 79 |
Schaefer HM. Long-Term Management of the Kidney Transplant Recipient. Transplantation Surgery 2021. [DOI: 10.1007/978-3-030-55244-2_12] [Reference Citation Analysis]
|
| 80 |
Demir ME, Merhametsiz Ö, Sevmi̇s M, Aktas S, Uyar M. Diltiazem Böbrek Alıcılarında Greft Fonksiyonlarını İyileştirir mi? Harran Üniversitesi Tıp Fakültesi Dergisi 2020. [DOI: 10.35440/hutfd.815458] [Reference Citation Analysis]
|
| 81 |
Bashir S, Hussain M, Ali Khan A, Hassan U, Mushtaq KS, Hameed M, Awan UA. Renal Transplant Pathology: Demographic Features and Histopathological Analysis of the Causes of Graft Dysfunction. Int J Nephrol 2020;2020:7289701. [PMID: 33489373 DOI: 10.1155/2020/7289701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 82 |
Cravedi P, Fribourg M, Zhang W, Yi Z, Zaslavsky E, Nudelman G, Anderson L, Hartzell S, Brouard S, Heeger PS. Distinct peripheral blood molecular signature emerges with successful tacrolimus withdrawal in kidney transplant recipients. Am J Transplant 2020;20:3477-85. [PMID: 32459070 DOI: 10.1111/ajt.15979] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 83 |
Bertrand D, Terrec F, Etienne I, Chavarot N, Sberro R, Gatault P, Garrouste C, Bouvier N, Grall-Jezequel A, Jaureguy M, Caillard S, Thervet E, Colosio C, Golbin L, Rerolle JP, Thierry A, Sayegh J, Janbon B, Malvezzi P, Jouve T, Rostaing L, Noble J. Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort. J Clin Med 2020;9:E3479. [PMID: 33126667 DOI: 10.3390/jcm9113479] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 84 |
Ortega-Trejo JA, Pérez-Villalva R, Arreola-Guerra JM, Ramírez V, Sifuentes-Osornio J, Bobadilla NA. Effect of Fosfomycin on Cyclosporine Nephrotoxicity. Antibiotics (Basel) 2020;9:E720. [PMID: 33096599 DOI: 10.3390/antibiotics9100720] [Reference Citation Analysis]
|
| 85 |
Hoppmann N, Massoud O. Medical care of liver transplant patients. Expert Rev Gastroenterol Hepatol 2020;14:901-18. [PMID: 32684007 DOI: 10.1080/17474124.2020.1797483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 86 |
Ellingsen AR, Jørgensen KA, Østerby R, Petersen SE, Juul S, Marcussen N, Nyengaard JR. Human kidney graft survival correlates with structural parameters in baseline biopsies: a quantitative observational cohort study with more than 14 years' follow-up. Virchows Arch 2021;478:659-68. [PMID: 32986179 DOI: 10.1007/s00428-020-02924-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 87 |
Bézie S, Charreau B, Vimond N, Lasselin J, Gérard N, Nerrière-Daguin V, Bellier-Waast F, Duteille F, Anegon I, Guillonneau C. Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice. Blood Adv 2019;3:3522-38. [PMID: 31730699 DOI: 10.1182/bloodadvances.2019000411] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 88 |
Choi M, Bachmann F, Wu K, Lachmann N, Schmidt D, Brakemeier S, Duerr M, Kahl A, Eckardt KU, Budde K, Nickel P. Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept. BMC Nephrol 2020;21:354. [PMID: 32819287 DOI: 10.1186/s12882-020-01992-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 89 |
Leino AD, Pai MP. Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose Selection. Clin Pharmacokinet 2020;59:1317-34. [PMID: 32720300 DOI: 10.1007/s40262-020-00923-w] [Reference Citation Analysis]
|
| 90 |
Gutiérrez-larrañaga M, López-hoyos M, Renaldo A, San Segundo D. Non-HLA Abs in Solid Organ Transplantation. Transplantology 2020;1:24-41. [DOI: 10.3390/transplantology1010003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 91 |
Tjon J, Teoh CW. Medication-Induced Nephrotoxicity in Children. Curr Pediatr Rep 2020;8:122-33. [DOI: 10.1007/s40124-020-00223-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 92 |
van der Zwan M, Hesselink DA, van den Hoogen MWF, Baan CC. Costimulation Blockade in Kidney Transplant Recipients. Drugs 2020;80:33-46. [PMID: 31749062 DOI: 10.1007/s40265-019-01226-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 93 |
Sotomayor CG, Te Velde-Keyzer CA, de Borst MH, Navis GJ, Bakker SJL. Lifestyle, Inflammation, and Vascular Calcification in Kidney Transplant Recipients: Perspectives on Long-Term Outcomes. J Clin Med 2020;9:E1911. [PMID: 32570920 DOI: 10.3390/jcm9061911] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 94 |
Navarrete M, Korkmaz B, Guarino C, Lesner A, Lao Y, Ho J, Nickerson P, Wilkins JA. Activity-based protein profiling guided identification of urine proteinase 3 activity in subclinical rejection after renal transplantation. Clin Proteomics 2020;17:23. [PMID: 32549867 DOI: 10.1186/s12014-020-09284-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 95 |
Park JB. Future direction of immunosuppressive treatment in organ transplantation. J Korean Med Assoc 2020;63:259-266. [DOI: 10.5124/jkma.2020.63.5.259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 96 |
Rodriguez-Barbosa JI, Schneider P, Graca L, Bühler L, Perez-Simon JA, Del Rio ML. The Role of TNFR2 and DR3 in the In Vivo Expansion of Tregs in T Cell Depleting Transplantation Regimens. Int J Mol Sci 2020;21:E3347. [PMID: 32397343 DOI: 10.3390/ijms21093347] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 97 |
Lim SW, Luo K, Quan Y, Cui S, Shin YJ, Ko EJ, Chung BH, Yang CW. The safety, immunological benefits, and efficacy of ginseng in organ transplantation. J Ginseng Res 2020;44:399-404. [PMID: 32372861 DOI: 10.1016/j.jgr.2020.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 98 |
Cheng CH, Lee CF, Oh BC, Furtmüller GJ, Patel CH, Brandacher G, Powell JD. Targeting Metabolism as a Platform for Inducing Allograft Tolerance in the Absence of Long-Term Immunosuppression. Front Immunol 2020;11:572. [PMID: 32328063 DOI: 10.3389/fimmu.2020.00572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 99 |
Artemov DV, Zulkarnaev AB, Vatazin AV. Age-related features of the pattern of lymphocyte subpopulations and functional activity of peripheral blood mononuclear cells in patients with chronic kidney disease before and after transplantation. RJTAO 2020;22:40-9. [DOI: 10.15825/1995-1191-2020-1-40-49] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 100 |
Moreso F, Sellarès J, Soler MJ, Serón D. Transcriptome Analysis in Renal Transplant Biopsies Not Fulfilling Rejection Criteria. Int J Mol Sci 2020;21:E2245. [PMID: 32213927 DOI: 10.3390/ijms21062245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 101 |
Naik AS, Afshinnia F, Aqeel J, Cibrik DM, Samaniego M, Wickman L, Wang SQ, Chowdhury M, Wiggins RC. Accelerated podocyte detachment early after kidney transplantation is related to long-term allograft loss of function. Nephrol Dial Transplant 2019;34:1232-9. [PMID: 30500951 DOI: 10.1093/ndt/gfy350] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 102 |
Bolboacă SD, Elec FI, Elec AD, Muntean AM, Socaciu MA, Iacob G, Zaro R, Andrieș AI, Bădulescu RM, Ignat RM, Iancu M, Badea RI. Shear-Wave Elastography Variability Analysis and Relation with Kidney Allograft Dysfunction: A Single-Center Study. Diagnostics (Basel) 2020;10:E41. [PMID: 31941112 DOI: 10.3390/diagnostics10010041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 103 |
Bang JB, Oh CK, Ju MK, Kim SJ, Yu HC, Lee SH. Clinical Study of Standard- vs Reduced-Dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Kidney Transplantation: A Prospective Randomized Trial. Transplant Proc 2020;52:133-9. [PMID: 31898939 DOI: 10.1016/j.transproceed.2019.11.029] [Reference Citation Analysis]
|
| 104 |
Farouk SS, Rein JL. The Many Faces of Calcineurin Inhibitor Toxicity-What the FK? Adv Chronic Kidney Dis 2020;27:56-66. [PMID: 32147003 DOI: 10.1053/j.ackd.2019.08.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 105 |
La Muraglia GM 2nd, Wagener ME, Ford ML, Badell IR. Circulating T follicular helper cells are a biomarker of humoral alloreactivity and predict donor-specific antibody formation after transplantation. Am J Transplant 2020;20:75-87. [PMID: 31250973 DOI: 10.1111/ajt.15517] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 106 |
Guitynavard F, Aghamir SMK, Taheri D. Transplant and Kidney Repair. Stem Cells in Urology 2020. [DOI: 10.1007/978-3-030-41476-4_8] [Reference Citation Analysis]
|
| 107 |
Taylor AT. Nuclear Medicine Imaging Techniques of the Kidney. Clinical Nuclear Medicine 2020. [DOI: 10.1007/978-3-030-39457-8_8] [Reference Citation Analysis]
|
| 108 |
Morsi M, Ciancio G, Gonzalez J, Farag A, Vianna R. Pancreas transplantation in the setting of multivisceral transplantation. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas 2020. [DOI: 10.1016/b978-0-12-814833-4.00015-0] [Reference Citation Analysis]
|
| 109 |
Kim Y. Pathology of the Allograft Kidney. Kidney Transplantation in Sensitized Patients 2020. [DOI: 10.1007/978-981-10-7046-4_8] [Reference Citation Analysis]
|
| 110 |
Päivärinta J, Oikonen V, Räisänen-Sokolowski A, Tolvanen T, Löyttyniemi E, Iida H, Nuutila P, Metsärinne K, Koivuviita N. Renal vascular resistance is increased in patients with kidney transplant. BMC Nephrol 2019;20:437. [PMID: 31775670 DOI: 10.1186/s12882-019-1617-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 111 |
Parsons RF, Larsen CP, Pearson TC, Badell IR. Belatacept and CD28 Costimulation Blockade: Preventing and Reducing Alloantibodies over the Long Term. Curr Transplant Rep 2019;6:277-84. [PMID: 32158639 DOI: 10.1007/s40472-019-00260-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 112 |
Lammerts RGM, Eisenga MF, Alyami M, Daha MR, Seelen MA, Pol RA, van den Born J, Sanders JS, Bakker SJL, Berger SP. Urinary Properdin and sC5b-9 Are Independently Associated With Increased Risk for Graft Failure in Renal Transplant Recipients. Front Immunol 2019;10:2511. [PMID: 31736953 DOI: 10.3389/fimmu.2019.02511] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 113 |
Brasile L, Henry N, Orlando G, Stubenitsky B. Potentiating Renal Regeneration Using Mesenchymal Stem Cells. Transplantation 2019;103:307-13. [PMID: 30234788 DOI: 10.1097/TP.0000000000002455] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 114 |
Hiramitsu T, Tomosugi T, Futamura K, Okada M, Goto N, Ichimori T, Narumi S, Watarai Y. Optimal dose of everolimus administered with tacrolimus in living donor kidney transplantation. Int Immunopharmacol 2019;75:105772. [PMID: 31376625 DOI: 10.1016/j.intimp.2019.105772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 115 |
Clayton PA, McDonald SP, Russ GR, Chadban SJ. Long-Term Outcomes after Acute Rejection in Kidney Transplant Recipients: An ANZDATA Analysis. J Am Soc Nephrol 2019;30:1697-707. [PMID: 31308074 DOI: 10.1681/ASN.2018111101] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 116 |
Magee CN, Murakami N, Borges TJ, Shimizu T, Safa K, Ohori S, Cai S, Uffing A, Azzi J, Elyaman W, Charbonnier LM, Liu K, Toprak D, Visner G, Chatila TA, Siebel CW, Najafian N, Riella LV. Notch-1 Inhibition Promotes Immune Regulation in Transplantation Via Regulatory T Cell-Dependent Mechanisms. Circulation 2019;140:846-63. [PMID: 31266349 DOI: 10.1161/CIRCULATIONAHA.119.040563] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 117 |
Zhang W, Yi Z, Wei C, Keung KL, Sun Z, Xi C, Woytovich C, Farouk S, Gallon L, Menon MC, Magee C, Najafian N, Samaniego MD, Djamali A, Alexander SI, Rosales IA, Smith RN, O'Connell PJ, Colvin R, Cravedi P, Murphy B. Pretransplant transcriptomic signature in peripheral blood predicts early acute rejection. JCI Insight 2019;4:127543. [PMID: 31167967 DOI: 10.1172/jci.insight.127543] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 118 |
Traitanon O, Mathew JM, Shetty A, Bontha SV, Maluf DG, El Kassis Y, Park SH, Han J, Ansari MJ, Leventhal JR, Mas V, Gallon L. Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil. PLoS One 2019;14:e0216300. [PMID: 31136582 DOI: 10.1371/journal.pone.0216300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 119 |
Mo H, Kim SY, Min S, Han A, Ahn S, Min SK, Lee H, Ahn C, Kim Y, Ha J. Association of Intrapatient Variability of Tacrolimus Concentration With Early Deterioration of Chronic Histologic Lesions in Kidney Transplantation. Transplant Direct 2019;5:e455. [PMID: 31321291 DOI: 10.1097/TXD.0000000000000899] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 120 |
Rajab A, Pelletier RP. mTOR Inhibitor in Combination with Cyclosporine as Primary Maintenance Immunosuppression in Combined Kidney/Pancreas Transplant Recipients. Curr Transpl Rep 2019;6:201-8. [DOI: 10.1007/s40472-019-00246-1] [Reference Citation Analysis]
|
| 121 |
Nanmoku K, Shinzato T, Kubo T, Shimizu T, Yagisawa T. Conversion to Everolimus in Kidney Transplant Recipients With Calcineurin Inhibitor-Induced Nephropathy: 3 Case Reports. Transplant Proc 2019;51:1424-7. [PMID: 31060742 DOI: 10.1016/j.transproceed.2019.01.131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 122 |
Matas AJ, Fieberg A, Mannon RB, Leduc R, Grande J, Kasiske BL, Cecka M, Gaston R, Hunsicker L, Connett J, Cosio F, Gourishankar S, Rush D. Long-term follow-up of the DeKAF cross-sectional cohort study. Am J Transplant 2019;19:1432-43. [PMID: 30506642 DOI: 10.1111/ajt.15204] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 123 |
Uchida J, Kosoku A, Kabei K, Nishide S, Shimada H, Iwai T, Kuwabara N, Naganuma T, Maeda K, Yoshikawa Y, Kumada N, Takemoto Y, Nakatani T. Pilot Experience with ABO-Incompatible Kidney Transplantation as a Second Transplant. Urol Int 2019;102:441-8. [PMID: 30991400 DOI: 10.1159/000499490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 124 |
Yang C, Wu S, Yang P, Shang G, Qi R, Xu M, Rong R, Zhu T, He W. Prediction of renal allograft chronic rejection using a model based on contrast-enhanced ultrasonography. Microcirculation. 2019;26:e12544. [PMID: 30887637 DOI: 10.1111/micc.12544] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 125 |
Zhuang Q, Cheng K, Ming Y. CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe? Curr Gene Ther 2017;17:442-52. [PMID: 29446734 DOI: 10.2174/1566523218666180214092536] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 126 |
Ho J, Sharma A, Kroeker K, Carroll R, De Serres S, Gibson IW, Hirt-Minkowski P, Jevnikar A, Kim SJ, Knoll G, Rush DN, Wiebe C, Nickerson P. Multicentre randomised controlled trial protocol of urine CXCL10 monitoring strategy in kidney transplant recipients. BMJ Open 2019;9:e024908. [PMID: 30975673 DOI: 10.1136/bmjopen-2018-024908] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
|
| 127 |
Moudgil A, Dharnidharka VR, Feig DI, Warshaw BL, Perera V, Murthy B, Roberts ME, Polinsky MS, Ettenger RB. Phase I study of single-dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients. Am J Transplant 2019;19:1218-23. [PMID: 30582294 DOI: 10.1111/ajt.15236] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 128 |
Sallustio BC, Noll BD, Coller JK, Tuke J, Russ G, Somogyi AA. Relationship between allograft cyclosporin concentrations and P-glycoprotein expression in the 1st month following renal transplantation. Br J Clin Pharmacol 2019;85:1015-20. [PMID: 30690767 DOI: 10.1111/bcp.13880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 129 |
Rovira J, Ramírez-Bajo MJ, Banon-Maneus E, Lazo-Rodríguez M, Moya-Rull D, Hierro-Garcia N, Tubita V, Piñeiro GJ, Revuelta I, Ventura-Aguiar P, Cucchiari D, Oppenheimer F, Brunet M, Campistol JM, Diekmann F. Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection. Transplantation 2018;102:1075-84. [PMID: 29620612 DOI: 10.1097/TP.0000000000002204] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 130 |
Wang Y, Pang L, Zhang Y, Lin J, Zhou H. Fenofibrate Improved Interstitial Fibrosis of Renal Allograft through Inhibited Epithelial-Mesenchymal Transition Induced by Oxidative Stress. Oxid Med Cell Longev 2019;2019:8936856. [PMID: 30911353 DOI: 10.1155/2019/8936856] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 131 |
Thomas MG, Bayliss C, Bond S, Dowling F, Galea J, Jairath V, Lamb C, Probert C, Timperley-Preece E, Watson A, Whitehead L, Williams JG, Parkes M, Kaser A, Raine T. Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial. BMJ Open 2019;9:e023765. [PMID: 30772849 DOI: 10.1136/bmjopen-2018-023765] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 132 |
Oguchi H, Sakai K, Yamaguchi Y, Mikami T, Nemoto T, Ohashi Y, Kawamura T, Muramatsu M, Itabashi Y, Shinoda K, Hyodo Y, Takahashi Y, Kawaguchi Y, Onishi H, Hamasaki Y, Shibuya K, Shishido S. Vasa recta hyalinosis reflects severe arteriolopathy in renal allografts. Clin Exp Nephrol 2019;23:799-806. [PMID: 30734165 DOI: 10.1007/s10157-019-01709-6] [Reference Citation Analysis]
|
| 133 |
Hemmersbach-Miller M, Wolfe CR, Schmader KE. Solid organ transplantation in older adults. Infectious and other age-related considerations. OBM Transplant 2019;3. [PMID: 34113803 DOI: 10.21926/obm.transplant.1901046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 134 |
Eder M, Schwarz C, Kammer M, Jacobsen N, Stavroula ML, Cowan MJ, Chongkrairatanakul T, Gaston R, Ravanan R, Ishida H, Bachmann A, Alvarez S, Koch M, Garrouste C, Duffner UA, Cullis B, Schaap N, Medinger M, Sørensen SS, Dauber EM, Böhmig G, Regele H, Berlakovich GA, Wekerle T, Oberbauer R. Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis. Am J Transplant 2019;19:475-87. [PMID: 29900661 DOI: 10.1111/ajt.14970] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 135 |
Hanaoka K, Maeda M, Tsujimoto S, Oshima S, Fukahori H, Nakamura K, Noto T, Higashi Y, Hirose J, Takakura S, Morokata T. Benefits of a loading dose of tacrolimus on graft survival of kidney transplants in nonhuman primates. Transplant Immunology 2019;52:32-9. [DOI: 10.1016/j.trim.2018.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 136 |
Sharma A, Cherukuri A, Mehta RB, Sood P, Hariharan S. High Calcineurin Inhibitor Intrapatient Variability Is Associated With Renal Allograft Inflammation, Chronicity, and Graft Loss. Transplant Direct 2019;5:e424. [PMID: 30882028 DOI: 10.1097/TXD.0000000000000862] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 137 |
Yang C, Qi R, Yang B. Pathogenesis of Chronic Allograft Dysfunction Progress to Renal Fibrosis. Adv Exp Med Biol 2019;1165:101-16. [PMID: 31399963 DOI: 10.1007/978-981-13-8871-2_6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 138 |
Tönshoff B. Immunosuppressants in Organ Transplantation. Handb Exp Pharmacol 2020;261:441-69. [PMID: 31820175 DOI: 10.1007/164_2019_331] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 139 |
Hossain MA, Chadha R, Bagul A, Motallebzadeh R. Kidney Transplantation. In Clinical Practice 2019. [DOI: 10.1007/978-3-030-21370-1_2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 140 |
Nankivell BJ. Chronic Allograft Failure. Kidney Transplantation - Principles and Practice 2019. [DOI: 10.1016/b978-0-323-53186-3.00027-9] [Reference Citation Analysis]
|
| 141 |
Gaston RS, Agarwal G, Morris SPJ. Azathioprine and Mycophenolates. Kidney Transplantation - Principles and Practice 2019. [DOI: 10.1016/b978-0-323-53186-3.00015-2] [Reference Citation Analysis]
|
| 142 |
O’connell PJ, Keung KL, Menon MC, Murphy B. Biomarkers of Kidney Injury and Rejection. Kidney Transplantation - Principles and Practice 2019. [DOI: 10.1016/b978-0-323-53186-3.00026-7] [Reference Citation Analysis]
|
| 143 |
Mejia-vilet JM, Rovin BH. Epidemiology and Management of Lupus Nephritis. Dubois' Lupus Erythematosus and Related Syndromes 2019. [DOI: 10.1016/b978-0-323-47927-1.00059-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 144 |
Farris AB, Cornell LD, Colvin RB. Pathology of Kidney Transplantation. Kidney Transplantation - Principles and Practice 2019. [DOI: 10.1016/b978-0-323-53186-3.00025-5] [Reference Citation Analysis]
|
| 145 |
Butani L. Immunosuppressive Medications in Kidney Transplantation. Adolescents with Chronic Kidney Disease 2019. [DOI: 10.1007/978-3-319-97220-6_14] [Reference Citation Analysis]
|
| 146 |
Chancharoenthana W, Leelahavanichkul A, Wattanatorn S, Avihingsanon Y, Praditpornsilpa K, Eiam-Ong S, Townamchai N. Alteration of urinary neutrophil gelatinase-associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation. PLoS One 2018;13:e0209708. [PMID: 30576367 DOI: 10.1371/journal.pone.0209708] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 147 |
Rifkin WJ, Bellamy JL, Kantar RS, Farber SJ, Diaz-Siso JR, Brecht LE, Rodriguez ED. Autologous Reconstruction of a Face Transplant Candidate. Craniomaxillofac Trauma Reconstr 2019;12:150-5. [PMID: 31073366 DOI: 10.1055/s-0038-1675844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 148 |
van der Zwan M, Baan CC, Colvin RB, Smith RN, White RA, Ndishabandi D, Nigg AL, van den Bosch TPP, de Graav GN, Clahsen-van Groningen MC, Hesselink DA. Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients. Transplant Direct 2019;5:e418. [PMID: 30656216 DOI: 10.1097/TXD.0000000000000857] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 149 |
Pérez-Sáez MJ, Yu B, Uffing A, Murakami N, Borges TJ, Azzi J, El Haji S, Gabardi S, Riella LV. Conversion from tacrolimus to belatacept improves renal function in kidney transplant patients with chronic vascular lesions in allograft biopsy. Clin Kidney J 2019;12:586-91. [PMID: 31384452 DOI: 10.1093/ckj/sfy115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 150 |
Groenendyk J, Paskevicius T, Urra H, Viricel C, Wang K, Barakat K, Hetz C, Kurgan L, Agellon LB, Michalak M. Cyclosporine A binding to COX-2 reveals a novel signaling pathway that activates the IRE1α unfolded protein response sensor. Sci Rep 2018;8:16678. [PMID: 30420769 DOI: 10.1038/s41598-018-34891-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 151 |
Ming Y, Yu M. Gene Polymorphisms of Immunosuppressants in Solid Organ Transplantation. Genetic Diversity and Disease Susceptibility 2018. [DOI: 10.5772/intechopen.75717] [Reference Citation Analysis]
|
| 152 |
Sikma MA, Hunault CC, Kirkels JH, Verhaar MC, Kesecioglu J, de Lange DW. Association of Whole Blood Tacrolimus Concentrations with Kidney Injury in Heart Transplantation Patients. Eur J Drug Metab Pharmacokinet 2018;43:311-20. [PMID: 29236211 DOI: 10.1007/s13318-017-0453-7] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
|
| 153 |
Brilland B, Laplante P, Thebault P, Brissette M, Chassé M, Qi S, Cailhier J. L’absence de MFG-E8 aggrave le rejet dans un modèle murin de vasculopathie du transplant. Néphrologie & Thérapeutique 2018;14:404-405. [DOI: 10.1016/j.nephro.2018.07.350] [Reference Citation Analysis]
|
| 154 |
Marticorena Garcia SR, Guo J, Dürr M, Denecke T, Hamm B, Sack I, Fischer T. Comparison of ultrasound shear wave elastography with magnetic resonance elastography and renal microvascular flow in the assessment of chronic renal allograft dysfunction. Acta Radiol 2018;59:1139-45. [PMID: 29249167 DOI: 10.1177/0284185117748488] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 155 |
Kim DG, Kim BS, Choi HY, Lim BJ, Huh KH, Kim MS, Jeong HJ, Kim YS. Association between post-transplant uric acid level and renal allograft fibrosis: Analysis using Banff pathologic scores from renal biopsies. Sci Rep 2018;8:11601. [PMID: 30072753 DOI: 10.1038/s41598-018-29948-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 156 |
Webber AB, Tatapudi V, Maw TT, Peralta C, Leung JCY, Vincenti F. Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot Trial. Transplant Direct 2018;4:e369. [PMID: 30046659 DOI: 10.1097/TXD.0000000000000810] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 157 |
Andrade-sierra J, Vazquez-galvan PA, Hernandez-reyes H, Mercado-jáuregui LA, Chávez-iñiguez JS, González-espinoza E, Gómez-navarro B, Cerrillos-gutiérrez JI. Immunosuppressive Minimization Strategies in Kidney Transplantation. Organ Donation and Transplantation - Current Status and Future Challenges 2018. [DOI: 10.5772/intechopen.77292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 158 |
Yu X, Ruan L, Qu Z, Cui Z, Zhang Y, Wang X, Meng L, Liu X, Wang F, Zhang Y, Liu G, Yang L. Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety. Ren Fail 2017;39:688-97. [PMID: 28882100 DOI: 10.1080/0886022X.2017.1373130] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 159 |
Papazova DA, Krebber MM, Oosterhuis NR, Gremmels H, van Zuilen AD, Joles JA, Verhaar MC. Dissecting recipient from donor contribution in experimental kidney transplantation: focus on endothelial proliferation and inflammation. Dis Model Mech 2018;11:dmm035030. [PMID: 30038062 DOI: 10.1242/dmm.035030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 160 |
Eisenberger U, Budde K, Lehner F, Sommerer C, Reinke P, Witzke O, Wüthrich RP, Stahl R, Heller K, Suwelack B, Mühlfeld A, Hauser IA, Nadalin S, Porstner M, Arns W; ZEUS Study Investigators. Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study. BMC Nephrol 2018;19:154. [PMID: 29954336 DOI: 10.1186/s12882-018-0950-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 161 |
Torres Crigna A, Daniele C, Gamez C, Medina Balbuena S, Pastene DO, Nardozi D, Brenna C, Yard B, Gretz N, Bieback K. Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models. Front Med (Lausanne) 2018;5:179. [PMID: 29963554 DOI: 10.3389/fmed.2018.00179] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 162 |
3C Study Collaborative Group. Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial. Am J Transplant 2018;18:1424-34. [PMID: 29226570 DOI: 10.1111/ajt.14619] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 163 |
Wang Z, Divanyan A, Jourd'heuil FL, Goldman RD, Ridge KM, Jourd'heuil D, Lopez-Soler RI. Vimentin expression is required for the development of EMT-related renal fibrosis following unilateral ureteral obstruction in mice. Am J Physiol Renal Physiol 2018;315:F769-80. [PMID: 29631355 DOI: 10.1152/ajprenal.00340.2017] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 164 |
Désy O, Béland S, Vallin P, Riopel J, Latulippe E, Wagner E, De Serres SA. Allogeneic dendritic cells stimulated with antibodies against HLA class II polarize naive T cells in a follicular helper phenotype. Sci Rep 2018;8:4025. [PMID: 29507364 DOI: 10.1038/s41598-018-22391-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 165 |
Bentall A, Amer H. Mitigating Risk of Immunosuppression by Immune Monitoring. Transplantation 2018;102:349-350. [DOI: 10.1097/tp.0000000000002037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 166 |
Zhu N, Rowe NE, Martin PR, Luke SS, Mcgregor TB, Myslik F, Mcalister VC, Sener A, Luke PP. Long-term results of protocol kidney biopsy directing steroid withdrawal in simultaneous pancreas-kidney transplant patients. Can Urol Assoc J 2018;12:188-92. [PMID: 29485032 DOI: 10.5489/cuaj.4702] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 167 |
Bézie S, Meistermann D, Boucault L, Kilens S, Zoppi J, Autrusseau E, Donnart A, Nerrière-Daguin V, Bellier-Waast F, Charpentier E, Duteille F, David L, Anegon I, Guillonneau C. Ex Vivo Expanded Human Non-Cytotoxic CD8+CD45RClow/- Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice. Front Immunol 2017;8:2014. [PMID: 29445370 DOI: 10.3389/fimmu.2017.02014] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 168 |
Tatapudi VS, Lonze BE, Wu M, Montgomery RA. Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic Syndrome. Case Rep Nephrol Dial 2018;8:10-9. [PMID: 29594146 DOI: 10.1159/000486158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 169 |
Aziz MM, Eid NI, Nada AS, Amin NE, Ain-Shoka AA. Possible protective effect of the algae spirulina against nephrotoxicity induced by cyclosporine A and/or gamma radiation in rats. Environ Sci Pollut Res Int 2018;25:9060-70. [PMID: 29333572 DOI: 10.1007/s11356-017-1146-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 170 |
Kaiser BA, Polinsky MS. Immunosuppression: Induction, Maintenance, and Steroid Avoidance Protocols. Solid Organ Transplantation in Infants and Children 2018. [DOI: 10.1007/978-3-319-07284-5_32] [Reference Citation Analysis]
|
| 171 |
Ikeda N, Kono A. The Relationship between Health Habits, Medication Adherence, Kidney Function, and QOL among Kidney Transplant Patients. J Jpn Acad Nurs Sci 2018;38:365-373. [DOI: 10.5630/jans.38.365] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 172 |
Baluarte HJ, Palmer JA. Late Allograft Loss of Function: Recurrence of Disease, Chronic Allograft Injury (Immune and Nonimmune Mediated), and Retransplantation. Solid Organ Transplantation in Infants and Children 2018. [DOI: 10.1007/978-3-319-07284-5_34] [Reference Citation Analysis]
|
| 173 |
Vincenti F, Blancho G, Durrbach A, Grannas G, Grinyó J, Meier-Kriesche HU, Polinsky M, Yang L, Larsen CP. Ten-year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4-weekly or 8-weekly. Am J Transplant 2017;17:3219-27. [PMID: 28758341 DOI: 10.1111/ajt.14452] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 174 |
Lombardi A, Trimarco B, Iaccarino G, Santulli G. Impaired mitochondrial calcium uptake caused by tacrolimus underlies beta-cell failure. Cell Commun Signal 2017;15:47. [PMID: 29132395 DOI: 10.1186/s12964-017-0203-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 175 |
Adams AB, Goldstein J, Garrett C, Zhang R, Patzer RE, Newell KA, Turgeon NA, Chami AS, Guasch A, Kirk AD, Pastan SO, Pearson TC, Larsen CP. Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function. Am J Transplant 2017;17:2922-36. [PMID: 28544101 DOI: 10.1111/ajt.14353] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 176 |
Lannaman K, Romero R, Chaiworapongsa T, Kim YM, Korzeniewski SJ, Maymon E, Gomez-Lopez N, Panaitescu B, Hassan SS, Yeo L, Yoon BH, Jai Kim C, Erez O. Fetal death: an extreme manifestation of maternal anti-fetal rejection. J Perinat Med 2017;45:851-68. [PMID: 28862989 DOI: 10.1515/jpm-2017-0073] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 177 |
Matter YE. Live Donor Kidney Transplantation Pearls: A Practical Review. UNOAJ 2017;5. [DOI: 10.15406/unoaj.2017.05.00178] [Reference Citation Analysis]
|
| 178 |
Bia MJ. Slow Rise in Serum Creatinine Level in a Kidney Transplant Recipient 3 Years Post-Transplant. Clin J Am Soc Nephrol 2017;12:1692-4. [PMID: 28336817 DOI: 10.2215/CJN.12691216] [Reference Citation Analysis]
|
| 179 |
Zaitsu M, Issa F, Hester J, Vanhove B, Wood KJ. Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses. JCI Insight 2017;2:89381. [PMID: 28978798 DOI: 10.1172/jci.insight.89381] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 180 |
Newell KA, Mehta AK, Larsen CP, Stock PG, Farris AB, Mehta SG, Ikle D, Armstrong B, Morrison Y, Bridges N, Robien M, Mannon RB. Lessons Learned: Early Termination of a Randomized Trial of Calcineurin Inhibitor and Corticosteroid Avoidance Using Belatacept. Am J Transplant 2017;17:2712-9. [PMID: 28556519 DOI: 10.1111/ajt.14377] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 181 |
Smith A, Niu W, Desai A. The Effect of Conversion from a Calcineurin Inhibitor to Sirolimus on Skin Cancer Reduction in Post-renal Transplantation Patients. Cureus 2017;9:e1564. [PMID: 29057176 DOI: 10.7759/cureus.1564] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
|
| 182 |
Dai Z, Ye L, Chen D, Zhang X, Wang M, Wang R, Wu J, Chen J. Effect of earlier-proteinuria on graft functions after one-year living donor renal transplantation. Oncotarget 2017;8:59103-12. [PMID: 28938621 DOI: 10.18632/oncotarget.19260] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 183 |
Viero RM, Andrade LGMD. Renin-Angiotensin System and Renal Allograft Long-Term Outcome: A Review. Renin-Angiotensin System - Past, Present and Future 2017. [DOI: 10.5772/67082] [Reference Citation Analysis]
|
| 184 |
Gupta C, Moudgil A. Renal transplantation in children: Current status and challenges. Apollo Medicine 2017;14:88-99. [DOI: 10.1016/j.apme.2017.02.009] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 185 |
Singh H, Panta OB, Khanal U, Ghimire RK. Renal Cortical Elastography: Normal Values and Variations. J Med Ultrasound 2017;25:215-20. [PMID: 30065495 DOI: 10.1016/j.jmu.2017.04.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 186 |
Menon MC, Keung KL, Murphy B, OʼConnell PJ. The Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant Injury. Transplantation 2016;100:1405-14. [PMID: 26447506 DOI: 10.1097/TP.0000000000000943] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 187 |
Pereira LMS, Gomes STM, Ishak R, Vallinoto ACR. Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis. Front Immunol 2017;8:605. [PMID: 28603524 DOI: 10.3389/fimmu.2017.00605] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 188 |
Rohan VS, Chavin KD. Knowing the allograft's destiny. Transl Androl Urol 2017;6:313-4. [PMID: 28540243 DOI: 10.21037/tau.2017.03.27] [Reference Citation Analysis]
|
| 189 |
Medeiros M, Velásquez-Jones L, Hernández AM, Ramón-García G, Valverde S, Fuentes Y, Vargas A, Patiño M, Pérez-Villalva R, Ortega-Trejo JA, Barrera-Chimal J, Bobadilla NA. Randomized Controlled Trial of Mineralocorticoid Receptor Blockade in Children with Chronic Kidney Allograft Nephropathy. Clin J Am Soc Nephrol 2017;12:1291-300. [PMID: 28536123 DOI: 10.2215/CJN.05300516] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 190 |
Vanhove T, Goldschmeding R, Kuypers D. Kidney Fibrosis: Origins and Interventions. Transplantation 2017;101:713-26. [PMID: 27941433 DOI: 10.1097/TP.0000000000001608] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 191 |
Kim IK, Choi J, Vo AA, Kang A, Patel M, Toyoda M, Mirocha J, Kamil ES, Cohen JL, Louie S, Galera O, Jordan SC, Puliyanda DP. Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients. Transplantation 2017;101:883-9. [PMID: 27495773 DOI: 10.1097/TP.0000000000001416] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 192 |
Kumar D, LeCorchick S, Gupta G. Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants. Front Med (Lausanne) 2017;4:60. [PMID: 28580358 DOI: 10.3389/fmed.2017.00060] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 193 |
Ferreira A, Felipe C, Cristelli M, Viana L, Basso G, Stopa S, Mansur J, Ivani M, Bessa A, Ruppel P, Aguiar W, Campos E, Gerbase-DeLima M, Proença H, Tedesco-Silva H, Medina-Pestana J. Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus. Am J Nephrol 2017;45:497-508. [PMID: 28511172 DOI: 10.1159/000475888] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 194 |
Malvezzi P, Jouve T, Rostaing L. Costimulation Blockade in Kidney Transplantation: An Update. Transplantation 2016;100:2315-23. [PMID: 27472094 DOI: 10.1097/TP.0000000000001344] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 195 |
Alexander SI, Clayton PA, Chadban SJ. Organ Transplantation in Australia. Transplantation 2017;101:891-2. [PMID: 28437382 DOI: 10.1097/TP.0000000000001621] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 196 |
Cheunsuchon B, Sritippayawan S. Successful treatment of early allograft dysfunction with cinacalcet in a patient with nephrocalcinosis caused by severe hyperparathyroidism: a case report. BMC Res Notes 2017;10:153. [PMID: 28390426 DOI: 10.1186/s13104-017-2477-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 197 |
Wang Z, Han Z, Tao J, Wang J, Liu X, Zhou W, Xu Z, Zhao C, Wang Z, Tan R, Gu M. Role of endothelial-to-mesenchymal transition induced by TGF-β1 in transplant kidney interstitial fibrosis. J Cell Mol Med 2017;21:2359-69. [PMID: 28374926 DOI: 10.1111/jcmm.13157] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 198 |
Zhao Y, Su H, Shen X, Du J, Zhang X, Zhao Y. The immunological function of CD52 and its targeting in organ transplantation. Inflamm Res. 2017;66:571-578. [PMID: 28283679 DOI: 10.1007/s00011-017-1032-8] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 199 |
Rovira J, Diekmann F, Campistol JM, Ramírez-bajo MJ. Therapeutic application of extracellular vesicles in acute and chronic renal injury. Nefrología (English Edition) 2017;37:126-37. [DOI: 10.1016/j.nefroe.2017.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 200 |
Noreikaitė A, Saint-Marcoux F, Marquet P, Kaduševičius E, Stankevičius E. Influence of cyclosporine and everolimus on the main mycophenolate mofetil pharmacokinetic parameters: Cross-sectional study. Medicine (Baltimore) 2017;96:e6469. [PMID: 28353583 DOI: 10.1097/MD.0000000000006469] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 201 |
Ramachandran R, Yadav AK, Kumar V, Siva Tez Pinnamaneni V, Nada R, Ghosh R, Kumar V, Rathi M, Kohli HS, Gupta KL, Sakhuja V, Jha V. Two-Year Follow-up Study of Membranous Nephropathy Treated With Tacrolimus and Corticosteroids Versus Cyclical Corticosteroids and Cyclophosphamide. Kidney Int Rep 2017;2:610-6. [PMID: 29142979 DOI: 10.1016/j.ekir.2017.02.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 202 |
Sikma MA, Hunault CC, van de Graaf EA, Verhaar MC, Kesecioglu J, de Lange DW, Meulenbelt J. High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury. Eur J Clin Pharmacol 2017;73:573-80. [PMID: 28132082 DOI: 10.1007/s00228-017-2204-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 203 |
Sushkov AI. REPEAT KIDNEY TRANSPLANTATION. RJTAO 2017;18:157-169. [DOI: 10.15825/1995-1191-2016-4-157-169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 204 |
Boratyńska M, Patrzałek D. Transplantology: Challenges for Today. Arch Immunol Ther Exp (Warsz) 2016;64:37-45. [PMID: 28083612 DOI: 10.1007/s00005-016-0439-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 205 |
Amador CA, Bertocchio JP, Andre-Gregoire G, Placier S, Duong Van Huyen JP, El Moghrabi S, Berger S, Warnock DG, Chatziantoniou C, Jaffe IZ, Rieu P, Jaisser F. Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration. Kidney Int 2016;89:354-62. [PMID: 26422501 DOI: 10.1038/ki.2015.312] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 206 |
Li L, Greene I, Readhead B, Menon MC, Kidd BA, Uzilov AV, Wei C, Philippe N, Schroppel B, He JC. Novel Therapeutics Identification for Fibrosis in Renal Allograft Using Integrative Informatics Approach. Sci Rep. 2017;7:39487. [PMID: 28051114 DOI: 10.1038/srep39487] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 207 |
Depalma R, Knorr J, Navarro V. Immunology of Liver Transplantation. Contemporary Liver Transplantation 2017. [DOI: 10.1007/978-3-319-07209-8_20] [Reference Citation Analysis]
|
| 208 |
Danger R, Brouard S. Gene Expression Technology Applied to Kidney Transplantation. Kidney Transplantation, Bioengineering and Regeneration 2017. [DOI: 10.1016/b978-0-12-801734-0.00031-x] [Reference Citation Analysis]
|
| 209 |
Shetty AA, Tantissattamo E, Ho B, Skaro A, Zhao L, Montag S, Abecassis M. Graft and Patient Survival. Kidney Transplantation, Bioengineering and Regeneration 2017. [DOI: 10.1016/b978-0-12-801734-0.00039-4] [Reference Citation Analysis]
|
| 210 |
Florman S, Becker T, Bresnahan B, Chevaile-Ramos A, Carvalho D, Grannas G, Muehlbacher F, O'Connell PJ, Meier-Kriesche HU, Larsen CP. Efficacy and Safety Outcomes of Extended Criteria Donor Kidneys by Subtype: Subgroup Analysis of BENEFIT-EXT at 7 Years After Transplant. Am J Transplant 2017;17:180-90. [PMID: 27232116 DOI: 10.1111/ajt.13886] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 211 |
Menon MC, Cravedi P, El Salem F. Acute Cellular Rejection. Kidney Transplantation, Bioengineering and Regeneration 2017. [DOI: 10.1016/b978-0-12-801734-0.00032-1] [Reference Citation Analysis]
|
| 212 |
Rajalingam R. The Impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection. Front Immunol 2016;7:585. [PMID: 28066408 DOI: 10.3389/fimmu.2016.00585] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 213 |
Tariciotti L, Manzia TM, Sforza D, Anselmo A, Tisone G. Everolimus and Advagraf Ab Initio in Combined Liver and Kidney Transplant With Donor-Specific Antibodies: A Case Report. Transplant Proc 2016;48:3109-11. [PMID: 27932158 DOI: 10.1016/j.transproceed.2016.07.021] [Reference Citation Analysis]
|
| 214 |
Marinaki S, Boletis J. Immune Renal Injury: Similarities and Differences Between Glomerular Diseases and Transplantation. BANTAO Journal 2015;13:53-8. [DOI: 10.1515/bj-2015-0013] [Reference Citation Analysis]
|
| 215 |
Huuskes BM, Ricardo SD. Mesenchymal stromal cells targeting kidney disease. The Biology and Therapeutic Application of Mesenchymal Cells 2016. [DOI: 10.1002/9781118907474.ch51] [Reference Citation Analysis]
|
| 216 |
Durrbach A, Pestana JM, Florman S, Del Carmen Rial M, Rostaing L, Kuypers D, Matas A, Wekerle T, Polinsky M, Meier-Kriesche HU, Munier S, Grinyó JM. Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study. Am J Transplant 2016;16:3192-201. [PMID: 27130868 DOI: 10.1111/ajt.13830] [Cited by in Crossref: 98] [Cited by in F6Publishing: 99] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 217 |
Lionet A, Haeck M, Garstka A, Gnemmi V, Bazin D, Letavernier E, Haymann J, Noel C, Daudon M. First investigation on microcrystalline pathologies of kidney allografts through cellular scale physicochemical techniques. Comptes Rendus Chimie 2016;19:1542-7. [DOI: 10.1016/j.crci.2015.09.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 218 |
Žilinská Z, Dedinská I, Breza J Sr, Laca L. Impact of Trough Levels of Tacrolimus on Kidney Function and Graft Survival in Short and Longer Periods After Renal Transplantation. Transplant Proc 2016;48:2637-43. [PMID: 27788794 DOI: 10.1016/j.transproceed.2016.06.051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 219 |
Oberbauer R. Progression of Interstitial Fibrosis in Kidney Transplantation. Clin J Am Soc Nephrol 2016;11:2110-2. [PMID: 27797906 DOI: 10.2215/CJN.09770916] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 220 |
Heilman RL, Smith ML, Smith BH, Qaqish I, Khamash H, Singer AL, Kaplan B, Reddy KS. Progression of Interstitial Fibrosis during the First Year after Deceased Donor Kidney Transplantation among Patients with and without Delayed Graft Function. Clin J Am Soc Nephrol 2016;11:2225-32. [PMID: 27797897 DOI: 10.2215/CJN.05060516] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 221 |
Tsuchimoto A, Nakano T, Hasegawa S, Masutani K, Matsukuma Y, Eriguchi M, Nagata M, Nishiki T, Kitada H, Tanaka M, Kitazono T, Tsuruya K. The potential role of perivascular lymphatic vessels in preservation of kidney allograft function. Clin Exp Nephrol 2017;21:721-31. [PMID: 27770292 DOI: 10.1007/s10157-016-1338-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 222 |
Chung BH, Kim JH, Choi BS, Park CW, Kim JI, Moon IS, Kim YS, Choi YJ, Oh EJ, Yang CW. Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction. Korean J Intern Med 2018;33:157-67. [PMID: 27764540 DOI: 10.3904/kjim.2016.107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 223 |
Thuret R, Timsit MO, Kleinclauss F. [Chronic kidney disease and kidney transplantation]. Prog Urol 2016;26:882-908. [PMID: 27727091 DOI: 10.1016/j.purol.2016.09.051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 224 |
Kleinclauss F, Frontczak A, Terrier N, Thuret R, Timsit MO. [Immunology and immunosuppression in kidney transplantation. ABO and HLA incompatible kidney transplantation]. Prog Urol 2016;26:977-92. [PMID: 27670824 DOI: 10.1016/j.purol.2016.08.015] [Reference Citation Analysis]
|
| 225 |
Yadav RK, Lee GH, Lee HY, Li B, Jung HE, Rashid HO, Choi MK, Yadav BK, Kim WH, Kim KW, Park BH, Kim W, Lee YC, Kim HR, Chae HJ. TMBIM6 (transmembrane BAX inhibitor motif containing 6) enhances autophagy and reduces renal dysfunction in a cyclosporine A-induced nephrotoxicity model. Autophagy 2015;11:1760-74. [PMID: 26305401 DOI: 10.1080/15548627.2015.1082021] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 226 |
O'Connell PJ, Zhang W, Menon MC, Yi Z, Schröppel B, Gallon L, Luan Y, Rosales IA, Ge Y, Losic B, Xi C, Woytovich C, Keung KL, Wei C, Greene I, Overbey J, Bagiella E, Najafian N, Samaniego M, Djamali A, Alexander SI, Nankivell BJ, Chapman JR, Smith RN, Colvin R, Murphy B. Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicentre, prospective study. Lancet 2016;388:983-93. [PMID: 27452608 DOI: 10.1016/S0140-6736(16)30826-1] [Cited by in Crossref: 127] [Cited by in F6Publishing: 128] [Article Influence: 18.1] [Reference Citation Analysis]
|
| 227 |
Huang Y, Farkash E. Protocol Biopsies: Utility and Limitations. Adv Chronic Kidney Dis 2016;23:326-31. [PMID: 27742388 DOI: 10.1053/j.ackd.2016.09.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 228 |
Mckenna GJ. Is It Time to Use De Novo mTOR Inhibitors Posttransplant? Curr Transpl Rep 2016;3:244-253. [DOI: 10.1007/s40472-016-0111-z] [Reference Citation Analysis]
|
| 229 |
Wojciechowski D, Vincenti F. Costimulatory Blockade and Use of mTOR Inhibitors: Avoiding Injury Part 2. Adv Chronic Kidney Dis 2016;23:306-11. [PMID: 27742385 DOI: 10.1053/j.ackd.2016.09.004] [Reference Citation Analysis]
|
| 230 |
Prashar R, Venkat KK. Immunosuppression Minimization and Avoidance Protocols: When Less Is Not More. Adv Chronic Kidney Dis 2016;23:295-300. [PMID: 27742383 DOI: 10.1053/j.ackd.2016.09.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 231 |
Masola V, Zaza G, Gambaro G, Onisto M, Bellin G, Vischini G, Khamaysi I, Hassan A, Hamoud S, Nativ O, Heyman SN, Lupo A, Vlodavsky I, Abassi Z. Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. PLoS One 2016;11:e0160074. [PMID: 27467172 DOI: 10.1371/journal.pone.0160074] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 232 |
Paliege A, Bamoulid J, Bachmann F, Staeck O, Halleck F, Khadzhynov D, Brakemeier S, Dürr M, Budde K. [Immunosuppression and its use in kidney transplantation]. Urologe A 2015;54:1376-84. [PMID: 26459580 DOI: 10.1007/s00120-015-3909-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 233 |
Yeboah MM, Hye Khan MA, Chesnik MA, Sharma A, Paudyal MP, Falck JR, Imig JD. The epoxyeicosatrienoic acid analog PVPA ameliorates cyclosporine-induced hypertension and renal injury in rats. Am J Physiol Renal Physiol 2016;311:F576-85. [PMID: 27358055 DOI: 10.1152/ajprenal.00288.2016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 234 |
Stallone G, Infante B, Di Lorenzo A, Rascio F, Zaza G, Grandaliano G. mTOR inhibitors effects on regulatory T cells and on dendritic cells. J Transl Med 2016;14:152. [PMID: 27245075 DOI: 10.1186/s12967-016-0916-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 235 |
Yamanaka K, Kakuta Y, Nakazawa S, Kato T, Abe T, Imamura R, Okumi M, Ichimaru N, Kyo M, Kyakuno M, Takahara S, Nonomura N. Induction Immunosuppressive Therapy With Everolimus and Low-Dose Tacrolimus Extended-Release Preserves Good Renal Function at 1 Year After Kidney Transplantation. Transplant Proc 2016;48:781-5. [PMID: 27234735 DOI: 10.1016/j.transproceed.2015.12.077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 236 |
Naik AS, Afshinnia F, Cibrik D, Hodgin JB, Wu F, Zhang M, Kikuchi M, Wickman L, Samaniego M, Bitzer M, Wiggins JE, Ojo A, Li Y, Wiggins RC. Quantitative podocyte parameters predict human native kidney and allograft half-lives. JCI Insight 2016;1:86943. [PMID: 27280173 DOI: 10.1172/jci.insight.86943] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 237 |
Yan TZ, Wu XQ, Rong L. A four-drug combination therapy consisting of low-dose tacrolimus, low-dose mycophenolate mofetil, corticosteroids, and mizoribine in living donor renal transplantation: A randomized study. SAGE Open Med 2016;4:2050312116643672. [PMID: 27231549 DOI: 10.1177/2050312116643672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 238 |
Moes DJ, Press RR, Ackaert O, Ploeger BA, Bemelman FJ, Diack C, Wessels JA, van der Straaten T, Danhof M, Sanders JS, Homan van der Heide JJ, Guchelaar HJ, de Fijter JW. Exploring genetic and non-genetic risk factors for delayed graft function, acute and subclinical rejection in renal transplant recipients. Br J Clin Pharmacol 2016;82:227-37. [PMID: 27334415 DOI: 10.1111/bcp.12946] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 239 |
Bennett J, Cassidy H, Slattery C, Ryan MP, McMorrow T. Tacrolimus Modulates TGF-β Signaling to Induce Epithelial-Mesenchymal Transition in Human Renal Proximal Tubule Epithelial Cells. J Clin Med 2016;5:E50. [PMID: 27128949 DOI: 10.3390/jcm5050050] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 240 |
Bertocchio JP, Barbe C, Lavaud S, Toupance O, Nazeyrollas P, Jaisser F, Rieu P. Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A. PLoS One 2016;11:e0153635. [PMID: 27088859 DOI: 10.1371/journal.pone.0153635] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 241 |
Spatola L, Andrulli S. Doppler ultrasound in kidney diseases: a key parameter in clinical long-term follow-up. J Ultrasound. 2016;19:243-250. [PMID: 27965714 DOI: 10.1007/s40477-016-0201-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 242 |
Doronin DV, Chernyavskiy AM, Fomichev AV, Deryagin MN, Gorbatykh VN. ACUTE TACROLIMUS-INDUCED KIDNEY INSUFFICIENCY IN PATIENT AFTER HEART TRANSPLANTATION. RJTAO 2016;18:53-57. [DOI: 10.15825/1995-1191-2016-1-53-57] [Reference Citation Analysis]
|
| 243 |
Ghosh I, Rathi M. Mammalian target of rapamycin inhibitors: A paradigm shift in current immunosuppression protocols. Indian Journal of Transplantation 2016;10:33-39. [DOI: 10.1016/j.ijt.2016.05.001] [Reference Citation Analysis]
|
| 244 |
Hibberd AD, Clark DA, Trevillian PR, Mcelduff P. Interaction between castanospermine an immunosuppressant and cyclosporin A in rat cardiac transplantation. World J Transplant 2016; 6(1): 206-214 [PMID: 27011919 DOI: 10.5500/wjt.v6.i1.206] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 245 |
Khan A, Nasr P, El-Charabaty E, El-Sayegh S. An Insight Into the Immunologic Events and Risk Assessment in Renal Transplantation. J Clin Med Res 2016;8:367-72. [PMID: 27081421 DOI: 10.14740/jocmr2411w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 246 |
Jiménez C, López MO, Ros A, Aguilar A, Menendez D, Rivas B, Santana MJ, Vaca MA, Escuin F, Madero R, Selgas R. The Natural History of Kidney Graft Cortical Microcirculation Determined by Real-Time Contrast-Enhanced Sonography (RT-CES). PLoS One 2016;11:e0150384. [PMID: 26949940 DOI: 10.1371/journal.pone.0150384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 247 |
Tedesco-Silva H, Peddi VR, Sánchez-Fructuoso A, Marder BA, Russ GR, Diekmann F, Flynn A, Hahn CM, Li H, Tortorici MA, Schulman SL. Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients. Transplant Direct 2016;2:e69. [PMID: 27500260 DOI: 10.1097/TXD.0000000000000579] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 248 |
Venner JM, Famulski KS, Reeve J, Chang J, Halloran PF. Relationships among injury, fibrosis, and time in human kidney transplants. JCI Insight 2016;1:e85323. [PMID: 27699214 DOI: 10.1172/jci.insight.85323] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 249 |
Saat TC, van den Akker EK, IJzermans JN, Dor FJ, de Bruin RW. Improving the outcome of kidney transplantation by ameliorating renal ischemia reperfusion injury: lost in translation? J Transl Med 2016;14:20. [PMID: 26791565 DOI: 10.1186/s12967-016-0767-2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 250 |
Ozkan F, Goya C, Yildiz S, Duymus M, Menzilcioglu MS, Avcu S, Inci MF. Ultrasound Elastography in Kidney Disease. Biomarkers in Kidney Disease 2016. [DOI: 10.1007/978-94-007-7699-9_36] [Reference Citation Analysis]
|
| 251 |
Tönshoff B, Melk A, Höcker B. Immunosuppression in Pediatric Kidney Transplantation. Pediatric Kidney Disease 2016. [DOI: 10.1007/978-3-662-52972-0_67] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 252 |
Depalma R, Knorr J, Navarro V. Immunology of Liver Transplantation. Contemporary Liver Transplantation 2016. [DOI: 10.1007/978-3-319-05543-5_20-2] [Reference Citation Analysis]
|
| 253 |
Ali HA, Palmer SM, Manuel O. Special Considerations for Long-Term Survivors After Solid Organ Transplantation. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_53] [Reference Citation Analysis]
|
| 254 |
Maxwell H, Webb NJA. Chronic Renal Transplant Dysfunction. Pediatric Kidney Disease 2016. [DOI: 10.1007/978-3-662-52972-0_69] [Reference Citation Analysis]
|
| 255 |
Protocol Biopsies. Diagnostic Pathology: Kidney Diseases 2016. [DOI: 10.1016/b978-0-323-37707-2.50249-4] [Reference Citation Analysis]
|
| 256 |
Baluarte HJ, Palmer JA. Late Allograft Loss of Function: Recurrence of Disease, Chronic Allograft Injury (Immune and Nonimmune Mediated), and Re-transplantation. Solid Organ Transplantation in Infants and Children 2016. [DOI: 10.1007/978-3-319-08049-9_34-1] [Reference Citation Analysis]
|
| 257 |
Baron D, Giral M, Brouard S. Biomarkers of tolerance in kidney transplantation. Personalized Immunosuppression in Transplantation 2016. [DOI: 10.1016/b978-0-12-800885-0.00008-4] [Reference Citation Analysis]
|
| 258 |
Kaiser BA, Polinsky MS. Immunosuppression: Induction, Maintenance, and Steroid Avoidance Protocols. Solid Organ Transplantation in Infants and Children 2016. [DOI: 10.1007/978-3-319-08049-9_32-1] [Reference Citation Analysis]
|
| 259 |
Helanterä I, Ortiz F, Koskinen P. Chronic Allograft Damage Index (CADI) as a Biomarker in Kidney Transplantation. Biomarkers in Kidney Disease 2016. [DOI: 10.1007/978-94-007-7699-9_34] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 260 |
Mckenna GJ, Klintmalm GB. The Role of mTOR Inhibitors in Solid Organ Transplantation. Molecules to Medicine with mTOR 2016. [DOI: 10.1016/b978-0-12-802733-2.00023-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 261 |
Weir GC, Gaglia JL. Beta Cell Transplantation and Regeneration. Endocrinology: Adult and Pediatric 2016. [DOI: 10.1016/b978-0-323-18907-1.00050-0] [Reference Citation Analysis]
|
| 262 |
González F, Valjalo R. Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful. World J Transplant 2015; 5(4): 338-347 [PMID: 26722662 DOI: 10.5500/wjt.v5.i4.338] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 263 |
Vuiblet V, Fere M, Gobinet C, Birembaut P, Piot O, Rieu P. Renal Graft Fibrosis and Inflammation Quantification by an Automated Fourier-Transform Infrared Imaging Technique. J Am Soc Nephrol 2016;27:2382-91. [PMID: 26683669 DOI: 10.1681/ASN.2015050601] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 264 |
Fox AN, Brown RS. Liver Transplantation. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch108] [Reference Citation Analysis]
|
| 265 |
Vitalone MJ, Sigdel TK, Salomonis N, Sarwal RD, Hsieh SC, Sarwal MM. Transcriptional Perturbations in Graft Rejection. Transplantation 2015;99:1882-93. [PMID: 26154388 DOI: 10.1097/TP.0000000000000809] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 266 |
Bhatti AB, Usman M. Chronic Renal Transplant Rejection and Possible Anti-Proliferative Drug Targets. Cureus. 2015;7:e376. [PMID: 26677426 DOI: 10.7759/cureus.376] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 267 |
Reinders ME, Dreyer GJ, Bank JR, Roelofs H, Heidt S, Roelen DL, Zandvliet ML, Huurman VA, Fibbe WE, van Kooten C, Claas FH, Rabelink TJ, de Fijter JW. Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study. J Transl Med 2015;13:344. [PMID: 26537851 DOI: 10.1186/s12967-015-0700-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 268 |
Cargnin S, Quaglia M, Canonico PL, Stratta P, Terrazzino S. Impact of recipient ACE I/D genotype on kidney function in renal transplant patients: a meta-analysis of cross-sectional and longitudinal studies. Pharmacogenomics 2015;16:1887-902. [DOI: 10.2217/pgs.15.119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 269 |
Stevens RB, Foster KW, Miles CD, Kalil AC, Florescu DF, Sandoz JP, Rigley TH, Malik T, Wrenshall LE. A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology. PLoS One 2015;10:e0139247. [PMID: 26465152 DOI: 10.1371/journal.pone.0139247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 270 |
Zsom L, Wagner L, Fülöp T. Minimization vs tailoring: Where do we stand with personalized immunosuppression during renal transplantation in 2015? World J Transplant 2015; 5(3): 73-80 [PMID: 26421259 DOI: 10.5500/wjt.v5.i3.73] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 271 |
Zhou J, Qin L, Yi T, Ali R, Li Q, Jiao Y, Li G, Tobiasova Z, Huang Y, Zhang J, Yun JJ, Sadeghi MM, Giordano FJ, Pober JS, Tellides G. Interferon-γ-mediated allograft rejection exacerbates cardiovascular disease of hyperlipidemic murine transplant recipients. Circ Res 2015;117:943-55. [PMID: 26399469 DOI: 10.1161/CIRCRESAHA.115.306932] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 272 |
Bézie S, Picarda E, Ossart J, Tesson L, Usal C, Renaudin K, Anegon I, Guillonneau C. IL-34 is a Treg-specific cytokine and mediates transplant tolerance. J Clin Invest 2015;125:3952-64. [PMID: 26389674 DOI: 10.1172/JCI81227] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 273 |
Hartono C, Muthukumar T, Suthanthiran M. Biomarkers of allograft rejection and tolerance. Transplant Immunology 2015. [DOI: 10.1002/9781119072997.ch13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 274 |
Flechner SM. Optimizing immunosuppression: who can do more with less? Transpl Int 2016;29:20-2. [PMID: 26310496 DOI: 10.1111/tri.12676] [Reference Citation Analysis]
|
| 275 |
Hirt-Minkowski P, De Serres SA, Ho J. Developing renal allograft surveillance strategies - urinary biomarkers of cellular rejection. Can J Kidney Health Dis. 2015;2:28. [PMID: 26285614 DOI: 10.1186/s40697-015-0061-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 276 |
Zeisbrich M, Kihm LP, Drüschler F, Zeier M, Schwenger V. When is contrast-enhanced sonography preferable over conventional ultrasound combined with Doppler imaging in renal transplantation? Clin Kidney J 2015;8:606-14. [PMID: 26413289 DOI: 10.1093/ckj/sfv070] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 277 |
Bank JR, Rabelink TJ, de Fijter JW, Reinders ME. Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients. J Immunol Res. 2015;2015:391797. [PMID: 26258149 DOI: 10.1155/2015/391797] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 278 |
Borrego Hinojosa J, Gentil Govantes MA, Cabello Díaz M, Rodriguez Benot A, Mazuecos Blanca A, Osuna Ortega A, Bedoya Pérez R, Castro De La Nuez P, Alonso Gil M. Progression of urinary protein excretion after kidney transplantation: A marker for poor long-term prognosis. Nefrología (English Edition) 2015;35:374-84. [DOI: 10.1016/j.nefroe.2015.02.003] [Reference Citation Analysis]
|
| 279 |
Santos T, Santos L, Macário F, Romãozinho C, Alves R, Campos M, Mota A. New Recipes With Known Ingredients: Combined Therapy of Everolimus and Low-dose Tacrolimus in De Novo Renal Allograft Recipients. Transplant Proc 2015;47:906-10. [PMID: 26036483 DOI: 10.1016/j.transproceed.2015.03.042] [Reference Citation Analysis]
|
| 280 |
Birdwell KA, Decker B, Barbarino JM, Peterson JF, Stein CM, Sadee W, Wang D, Vinks AA, He Y, Swen JJ, Leeder JS, van Schaik R, Thummel KE, Klein TE, Caudle KE, MacPhee IA. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. Clin Pharmacol Ther. 2015;98:19-24. [PMID: 25801146 DOI: 10.1002/cpt.113] [Cited by in Crossref: 365] [Cited by in F6Publishing: 376] [Article Influence: 45.6] [Reference Citation Analysis]
|
| 281 |
Wedel J, Bruneau S, Kochupurakkal N, Boneschansker L, Briscoe DM. Chronic allograft rejection: a fresh look. Curr Opin Organ Transplant 2015;20:13-20. [PMID: 25563987 DOI: 10.1097/MOT.0000000000000155] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 282 |
Redfield RR, Scalea JR, Odorico JS. Simultaneous pancreas and kidney transplantation: current trends and future directions. Curr Opin Organ Transplant. 2015;20:94-102. [PMID: 25565444 DOI: 10.1097/mot.0000000000000146] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 283 |
Campistol JM, Gutiérrez-dalmau A, Crespo J, Saval N, Grinyó JM. Clinical approach to kidney disease in kidney recipients in Spain. Nefrología (English Edition) 2015;35:256-263. [DOI: 10.1016/j.nefroe.2015.06.005] [Reference Citation Analysis]
|
| 284 |
Ahn YH, Min SI, Ha J, Ha I, Cheong HI, Kang HG. Pharmacodynamic Monitoring of Calcineurin Inhibitor in Pediatric Kidney Transplantation. Korean J Transplant 2015;29:16-22. [DOI: 10.4285/jkstn.2015.29.1.16] [Reference Citation Analysis]
|
| 285 |
Hricik DE, Formica RN, Nickerson P, Rush D, Fairchild RL, Poggio ED, Gibson IW, Wiebe C, Tinckam K, Bunnapradist S, Samaniego-Picota M, Brennan DC, Schröppel B, Gaber O, Armstrong B, Ikle D, Diop H, Bridges ND, Heeger PS; Clinical Trials in Organ Transplantation-09 Consortium. Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients. J Am Soc Nephrol 2015;26:3114-22. [PMID: 25925687 DOI: 10.1681/ASN.2014121234] [Cited by in Crossref: 133] [Cited by in F6Publishing: 136] [Article Influence: 16.6] [Reference Citation Analysis]
|
| 286 |
Matas AJ, Gaston RS. Moving Beyond Minimization Trials in Kidney Transplantation. J Am Soc Nephrol 2015;26:2898-901. [PMID: 25925686 DOI: 10.1681/ASN.2015030245] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 287 |
Nadig SN, Dixit SK, Levey N, Esckilsen S, Miller K, Dennis W, Atkinson C, Broome AM. Immunosuppressive nano-therapeutic micelles downregulate endothelial cell inflammation and immunogenicity. RSC Adv 2015;5:43552-62. [PMID: 26167278 DOI: 10.1039/C5RA04057D] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 288 |
Stefanović NZ, Cvetković TP, Jevtović-Stoimenov TM, Zvezdanović-Čelebić LV, Stojanović DR, Ignjatović AM, Živković ND, Veličković-Radovanović RM. Potential role of tacrolimus in erythrocytes' antioxidative capacity in long-term period after renal transplantation. Eur J Pharm Sci 2015;70:132-9. [PMID: 25657088 DOI: 10.1016/j.ejps.2015.01.013] [Reference Citation Analysis]
|
| 289 |
Levine MH, Wang Z, Bhatti TR, Wang Y, Aufhauser DD, McNeal S, Liu Y, Cheraghlou S, Han R, Wang L, Hancock WW. Class-specific histone/protein deacetylase inhibition protects against renal ischemia reperfusion injury and fibrosis formation. Am J Transplant 2015;15:965-73. [PMID: 25708614 DOI: 10.1111/ajt.13106] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 290 |
Moyses Neto M, Romão EA, Silva GE, Dantas M, Nardim ME, Tucci S Jr, Francescato HD, Coimbra TM. Urinary monocyte chemoattractant protein-1 levels and interstitial changes in the renal cortex and their relationship with loss of renal function in renal transplant patients with delayed graft function. Can J Kidney Health Dis 2015;2:1. [PMID: 25780624 DOI: 10.1186/s40697-015-0038-9] [Reference Citation Analysis]
|
| 291 |
Gaber L, Croker BP. Non-neoplastic renal diseases. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology 2015. [DOI: 10.1017/9781139137201.032] [Reference Citation Analysis]
|
| 292 |
Boffa C, Barnes JC, Knight SR, Ploeg RJ. Protocol biopsies following kidney transplantation. Cochrane Database of Systematic Reviews 2015. [DOI: 10.1002/14651858.cd011540] [Reference Citation Analysis]
|
| 293 |
Pape L, Becker JU, Immenschuh S, Ahlenstiel T. Acute and chronic antibody-mediated rejection in pediatric kidney transplantation. Pediatr Nephrol 2015;30:417-24. [PMID: 24865478 DOI: 10.1007/s00467-014-2851-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 294 |
Stevens RB, Foster KW, Miles CD, Lane JT, Kalil AC, Florescu DF, Sandoz JP, Rigley TH, Nielsen KJ, Skorupa JY, Kellogg AM, Malik T, Wrenshall LE. A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes. Transplantation 2015;99:197-209. [PMID: 25083614 DOI: 10.1097/TP.0000000000000250] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 295 |
Iwase H, Ekser B, Satyananda V, Zhou H, Hara H, Bajona P, Wijkstrom M, Bhama JK, Long C, Veroux M, Wang Y, Dai Y, Phelps C, Ayares D, Ezzelarab MB, Cooper DK. Initial in vivo experience of pig artery patch transplantation in baboons using mutant MHC (CIITA-DN) pigs. Transpl Immunol 2015;32:99-108. [PMID: 25687023 DOI: 10.1016/j.trim.2015.02.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 296 |
Tsai EW, Reed EF. MHC class I signaling: new functional perspectives for an old molecule. Tissue Antigens 2014;83:375-81. [PMID: 24828054 DOI: 10.1111/tan.12381] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 297 |
Loupy A, Vernerey D, Tinel C, Aubert O, Duong van Huyen JP, Rabant M, Verine J, Nochy D, Empana JP, Martinez F, Glotz D, Jouven X, Legendre C, Lefaucheur C. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts. J Am Soc Nephrol 2015;26:1721-31. [PMID: 25556173 DOI: 10.1681/ASN.2014040399] [Cited by in Crossref: 206] [Cited by in F6Publishing: 213] [Article Influence: 25.8] [Reference Citation Analysis]
|
| 298 |
Depalma R, Knorr J, Navarro V. Immunology of Liver Transplantation. Contemporary Liver Transplantation 2015. [DOI: 10.1007/978-3-319-05543-5_20-1] [Reference Citation Analysis]
|
| 299 |
Wojciechowski D, Vincenti F. Novel Immunosuppressive Drugs. Transplantation of the Liver 2015. [DOI: 10.1016/b978-1-4557-0268-8.00095-6] [Reference Citation Analysis]
|
| 300 |
Helanterä I, Ortiz F, Koskinen P. Chronic Allograft Damage Index (CADI) as a Biomarker in Kidney Transplantation. Biomarkers in Kidney Disease 2015. [DOI: 10.1007/978-94-007-7743-9_34-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 301 |
Ozkan F, Goya C, Yildiz S, Duymus M, Menzilcioglu M, Avcu S, Inci MF. Ultrasound Elastography in Kidney Disease. Biomarkers in Kidney Disease 2015. [DOI: 10.1007/978-94-007-7743-9_36-1] [Reference Citation Analysis]
|
| 302 |
Sommerer C, Schaier M, Morath C, Schwenger V, Rauch G, Giese T, Zeier M. The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial. Trials 2014;15:489. [PMID: 25494823 DOI: 10.1186/1745-6215-15-489] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 303 |
Pazhayattil GS, Shirali AC. Drug-induced impairment of renal function. Int J Nephrol Renovasc Dis. 2014;7:457-468. [PMID: 25540591 DOI: 10.2147/ijnrd.s39747] [Cited by in Crossref: 41] [Cited by in F6Publishing: 65] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 304 |
Reinders ME, Bank JR, Dreyer GJ, Roelofs H, Heidt S, Roelen DL, Al Huurman V, Lindeman J, van Kooten C, Claas FH, Fibbe WE, Rabelink TJ, de Fijter JW. Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients. J Transl Med 2014;12:331. [PMID: 25491391 DOI: 10.1186/s12967-014-0331-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 305 |
Menon MC, Chuang PY, Li Z, Wei C, Zhang W, Luan Y, Yi Z, Xiong H, Woytovich C, Greene I, Overbey J, Rosales I, Bagiella E, Chen R, Ma M, Li L, Ding W, Djamali A, Saminego M, O'Connell PJ, Gallon L, Colvin R, Schroppel B, He JC, Murphy B. Intronic locus determines SHROOM3 expression and potentiates renal allograft fibrosis. J Clin Invest 2015;125:208-21. [PMID: 25437874 DOI: 10.1172/JCI76902] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 306 |
Roedder S, Li L, Alonso MN, Hsieh SC, Vu MT, Dai H, Sigdel TK, Bostock I, Macedo C, Metes D. A Three-Gene Assay for Monitoring Immune Quiescence in Kidney Transplantation. J Am Soc Nephrol. 2015;26:2042-2053. [PMID: 25429124 DOI: 10.1681/asn.2013111239] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 307 |
Masson P, Henderson L, Chapman JR, Craig JC, Webster AC. Belatacept for kidney transplant recipients. Cochrane Database Syst Rev. 2014: CD010699. [PMID: 25416857 DOI: 10.1002/14651858.cd010699.pub2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 68] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 308 |
Khan SQ, Guo L, Cimbaluk DJ, Elshabrawy H, Faridi MH, Jolly M, George JF, Agarwal A, Gupta V. A Small Molecule β2 Integrin Agonist Improves Chronic Kidney Allograft Survival by Reducing Leukocyte Recruitment and Accompanying Vasculopathy. Front Med (Lausanne) 2014;1:45. [PMID: 25593918 DOI: 10.3389/fmed.2014.00045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 309 |
Verghese PS, Dunn TB, Chinnakotla S, Gillingham KJ, Matas AJ, Mauer MS. Calcineurin inhibitors in HLA-identical living related donor kidney transplantation. Nephrol Dial Transplant 2014;29:209-18. [PMID: 24414376 DOI: 10.1093/ndt/gft447] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 310 |
Roedder S, Sigdel T, Salomonis N, Hsieh S, Dai H, Bestard O, Metes D, Zeevi A, Gritsch A, Cheeseman J, Macedo C, Peddy R, Medeiros M, Vincenti F, Asher N, Salvatierra O, Shapiro R, Kirk A, Reed EF, Sarwal MM. The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study. PLoS Med 2014;11:e1001759. [PMID: 25386950 DOI: 10.1371/journal.pmed.1001759] [Cited by in Crossref: 132] [Cited by in F6Publishing: 128] [Article Influence: 14.7] [Reference Citation Analysis]
|
| 311 |
Sangalli V, Dukes J, Doppalapudi SB, Costa G, Neri L. Work ability and labor supply after kidney transplantation. Am J Nephrol 2014;40:353-61. [PMID: 25358431 DOI: 10.1159/000365155] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 312 |
Thölking G, Fortmann C, Koch R, Gerth HU, Pabst D, Pavenstädt H, Kabar I, Hüsing A, Wolters H, Reuter S. The tacrolimus metabolism rate influences renal function after kidney transplantation. PLoS One. 2014;9:e111128. [PMID: 25340655 DOI: 10.1371/journal.pone.0111128] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 313 |
Wang L, Chen H, Liu XH, Chen ZY, Weng XD, Qiu T, Liu L, Zhu HC. Ozone oxidative preconditioning inhibits renal fibrosis induced by ischemia and reperfusion injury in rats. Exp Ther Med 2014;8:1764-8. [PMID: 25371729 DOI: 10.3892/etm.2014.2004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 314 |
Lalan S, Abdel-Rahman S, Gaedigk A, Leeder JS, Warady BA, Dai H, Blowey D. Effect of CYP3A5 genotype, steroids, and azoles on tacrolimus in a pediatric renal transplant population. Pediatr Nephrol 2014;29:2039-49. [PMID: 24875272 DOI: 10.1007/s00467-014-2827-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 315 |
Bröcker V, Mengel M. Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation. Pediatr Nephrol 2014;29:1939-49. [PMID: 24141526 DOI: 10.1007/s00467-013-2640-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 316 |
Shrestha B, Butt I, Da Silva M, Sanchez-Lara A, Wagner B, Raftery A, Johnson T, Haylor J. Upregulation of transglutaminase and ε (γ-glutamyl)-lysine in the Fisher-Lewis rat model of chronic allograft nephropathy. Biomed Res Int 2014;2014:651608. [PMID: 25143942 DOI: 10.1155/2014/651608] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 317 |
Stegall MD, Gaston RS, Cosio FG, Matas A. Through a glass darkly: seeking clarity in preventing late kidney transplant failure. J Am Soc Nephrol 2015;26:20-9. [PMID: 25097209 DOI: 10.1681/ASN.2014040378] [Cited by in Crossref: 93] [Cited by in F6Publishing: 95] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 318 |
Joo DJ, Yang CW, Jeong HJ, Lim BJ, Huh KH, Chung BH, Choi YJ, Kang SW, Kim YS. Sirolimus conversion efficacy for graft function improvement and histopathology in renal recipients with mild to moderate renal insufficiency. J Korean Med Sci 2014;29:1069-76. [PMID: 25120315 DOI: 10.3346/jkms.2014.29.8.1069] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 319 |
Reynolds BC, Talbot D, Baines L, Brown A. Use of belatacept to maintain adequate early immunosuppression in calcineurin-mediated microangiopathic hemolysis post-renal transplant. Pediatr Transplant 2014;18:E140-5. [PMID: 24815506 DOI: 10.1111/petr.12278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 320 |
Henderson LK, O’connell PJ. Recurrent Disease after Kidney and Pancreas Transplantation. Textbook of Organ Transplantation 2014. [DOI: 10.1002/9781118873434.ch77] [Reference Citation Analysis]
|
| 321 |
Nankivell BJ. Clinical Allograft Rejection Syndromes in Kidney Transplantation. Textbook of Organ Transplantation 2014. [DOI: 10.1002/9781118873434.ch69] [Reference Citation Analysis]
|
| 322 |
Stegall MD, Dean PG. Rescue Immunosuppressive Therapy. Textbook of Organ Transplantation 2014. [DOI: 10.1002/9781118873434.ch67] [Reference Citation Analysis]
|
| 323 |
Harmon W. Pediatric Kidney Transplantation. Textbook of Organ Transplantation 2014. [DOI: 10.1002/9781118873434.ch113] [Reference Citation Analysis]
|
| 324 |
Webber AB, Vincenti F. Future Pathways for Immune Manipulation. Textbook of Organ Transplantation 2014. [DOI: 10.1002/9781118873434.ch18] [Reference Citation Analysis]
|
| 325 |
Mihovilović K, Maksimović B, Kocman B, Guštin D, Vidas Z, Bulimbašić S, Ljubanović DG, Matovinović MS, Knotek M. Effect of mycophenolate mofetil on progression of interstitial fibrosis and tubular atrophy after kidney transplantation: a retrospective study. BMJ Open 2014;4:e005005. [PMID: 24993756 DOI: 10.1136/bmjopen-2014-005005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 326 |
Kim Y, Park S, Kim H, Han S. Actual 10-year Outcomes of Tacrolimus/MMF Compared with Cyclosporin/MMF in Kidney Transplantation. Korean J Transplant 2014;28:69-77. [DOI: 10.4285/jkstn.2014.28.2.69] [Reference Citation Analysis]
|
| 327 |
Mathis AS, Egloff G, Ghin HL. Calcineurin inhibitor sparing strategies in renal transplantation, part one: Late sparing strategies. World J Transplant 2014; 4(2): 57-80 [PMID: 25032096 DOI: 10.5500/wjt.v4.i2.57] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 328 |
Wedel J, Hottenrott MC, Stamellou E, Breedijk A, Tsagogiorgas C, Hillebrands JL, Yard BA. N-Octanoyl dopamine transiently inhibits T cell proliferation via G1 cell-cycle arrest and inhibition of redox-dependent transcription factors. J Leukoc Biol 2014;96:453-62. [PMID: 24929005 DOI: 10.1189/jlb.3A0813-455R] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 329 |
Torres IB, Moreso F, Sarró E, Meseguer A, Serón D. The Interplay between inflammation and fibrosis in kidney transplantation. Biomed Res Int. 2014;2014:750602. [PMID: 24991565 DOI: 10.1155/2014/750602] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 330 |
Guillén-Gómez E, Guirado L, Belmonte X, Maderuelo A, Santín S, Juarez C, Ars E, Facundo C, Ballarín JA, Vidal S, Díaz-Encarnación MM. Monocyte implication in renal allograft dysfunction. Clin Exp Immunol 2014;175:323-31. [PMID: 24134783 DOI: 10.1111/cei.12228] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 331 |
Yilmaz S. Chronic Allograft Nephropathy (Chronic Allograft Damage): Can It Be Avoided? Curr Transpl Rep 2014;1:91-99. [DOI: 10.1007/s40472-014-0009-6] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 332 |
Shrestha BM, Haylor J. Biological pathways and potential targets for prevention and therapy of chronic allograft nephropathy. Biomed Res Int 2014;2014:482438. [PMID: 24971332 DOI: 10.1155/2014/482438] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 333 |
Kern G, Mair SM, Noppert SJ, Jennings P, Schramek H, Rudnicki M, Mueller GA, Mayer G, Koppelstaetter C. Tacrolimus increases Nox4 expression in human renal fibroblasts and induces fibrosis-related genes by aberrant TGF-beta receptor signalling. PLoS One 2014;9:e96377. [PMID: 24816588 DOI: 10.1371/journal.pone.0096377] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 334 |
Kurian SM, Williams AN, Gelbart T, Campbell D, Mondala TS, Head SR, Horvath S, Gaber L, Thompson R, Whisenant T, Lin W, Langfelder P, Robison EH, Schaffer RL, Fisher JS, Friedewald J, Flechner SM, Chan LK, Wiseman AC, Shidban H, Mendez R, Heilman R, Abecassis MM, Marsh CL, Salomon DR. Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling. Am J Transplant 2014;14:1164-72. [PMID: 24725967 DOI: 10.1111/ajt.12671] [Cited by in Crossref: 83] [Cited by in F6Publishing: 87] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 335 |
Maluf DG, Dumur CI, Suh JL, Lee JK, Cathro EP, King AL, Gallon L, Brayman KL, Mas VR. Evaluation of molecular profiles in calcineurin inhibitor toxicity post-kidney transplant: input to chronic allograft dysfunction. Am J Transplant 2014;14:1152-63. [PMID: 24698514 DOI: 10.1111/ajt.12696] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 336 |
Ma A, Dun H, Song L, Hu Y, Zeng L, Bai J, Zhang G, Kinugasa F, Miyao Y, Sakuma S, Okimura K, Kasai N, Daloze P, Chen H. Pharmacokinetics and pharmacodynamics of ASKP1240, a fully human anti-CD40 antibody, in normal and renal transplanted Cynomolgus monkeys. Transplantation 2014;97:397-404. [PMID: 24389907 DOI: 10.1097/01.TP.0000440951.29757.bd] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 337 |
Jürgensen JS, Ikenberg R, Greiner RA, Hösel V. Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany. Eur J Health Econ 2015;16:377-90. [PMID: 24728542 DOI: 10.1007/s10198-014-0579-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 338 |
Janneck M, Velden J, Iking-Konert C. [Renal diseases in rheumatology]. Z Rheumatol 2013;72:555-68; quiz 569-70. [PMID: 23921983 DOI: 10.1007/s00393-013-1182-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 339 |
Khan H, Mubarak M, Aziz T, Ahmed E, Fazal Akhter S, Kazi J, Aa Naqvi S, Ah Rizvi S. Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program. J Nephropathol 2014;3:69-79. [PMID: 24772400 DOI: 10.12860/jnp.2014.15] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
|
| 340 |
Hong JW, Shin M, Moon HH, Lee S, Kim JM, Park JB, Kwon CHD, Joh J, Lee S, Kim S. Analysis of 1,500 Kidney Transplantations at Sungkyunkwan University. Korean J Transplant 2014;28:25-35. [DOI: 10.4285/jkstn.2014.28.1.25] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 341 |
Lukenda V, Mikolasevic I, Racki S, Jelic I, Stimac D, Orlic L. Transient elastography: a new noninvasive diagnostic tool for assessment of chronic allograft nephropathy. Int Urol Nephrol 2014;46:1435-40. [PMID: 24966148 DOI: 10.1007/s11255-014-0697-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 342 |
Wanitchanont A, Somparn P, Vadcharavivad S, Chancharoenthana W, Townamchai N, Praditpornsilpa K, Avihingsanon Y. Effects of atorvastatin on the pharmacokinetics of everolimus among kidney transplant recipients. Transplant Proc 2014;46:418-21. [PMID: 24655978 DOI: 10.1016/j.transproceed.2013.11.121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 343 |
Jun H, Jung C, Kim M, Park K. Experiences on Conversion to Once-Daily Advagraf and Sirolimus Combination in Stable Kidney Recipients. Transplantation Proceedings 2014;46:400-2. [DOI: 10.1016/j.transproceed.2014.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 344 |
Janneck M, Velden J, Iking-konert C. Renale Erkrankungen in der Rheumatologie. Nephrologe 2014;9:157-172. [DOI: 10.1007/s11560-014-0861-5] [Reference Citation Analysis]
|
| 345 |
Krisl JC, Alloway RR, Shields AR, Cardi MA, Woodle ES. Bortezomib-based antibody-mediated rejection therapy and simultaneous conversion to belatacept. Transplantation 2014;97:e30-2. [PMID: 24531826 DOI: 10.1097/01.TP.0000441824.95510.97] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 346 |
Finger EB, Strom TB, Matas AJ. Tolerance--is it worth it? Cold Spring Harb Perspect Med 2014;4:a015594. [PMID: 24370928 DOI: 10.1101/cshperspect.a015594] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 347 |
An GH, Yun J, Hong YA, Khvan M, Chung BH, Choi BS, Park CW, Choi YJ, Kim YS, Yang CW. The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients. J Immunol Res. 2014;2014:828732. [PMID: 24741626 DOI: 10.1155/2014/828732] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 348 |
Chadban SJ, Eris JM, Kanellis J, Pilmore H, Lee PC, Lim SK, Woodcock C, Kurstjens N, Russ G; SOCRATES Study Group. A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients. Transpl Int 2014;27:302-11. [PMID: 24279685 DOI: 10.1111/tri.12252] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 349 |
Chung BH, Yang CW. Current Issues in the Treatment of Chronic Antibody-Mediated Rejection in Kidney Transplantation. Hanyang Med Rev 2014;34:211. [DOI: 10.7599/hmr.2014.34.4.211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 350 |
Knechtle SJ, Pastan S. Early Course of the Patient with a Kidney Transplant. Kidney Transplantation–Principles and Practice 2014. [DOI: 10.1016/b978-1-4557-4096-3.00014-3] [Reference Citation Analysis]
|
| 351 |
Nankivell BJ. Chronic Allograft Failure. Kidney Transplantation–Principles and Practice 2014. [DOI: 10.1016/b978-1-4557-4096-3.00027-1] [Reference Citation Analysis]
|
| 352 |
Peraldi M. Transplantation rénale. Néphrologie et Troubles Hydro-électriques 2014. [DOI: 10.1016/b978-2-294-73759-6.00015-8] [Reference Citation Analysis]
|
| 353 |
Baker RJ. Long-Term Management of Kidney Transplant Recipients (KTRs). Practical Nephrology 2014. [DOI: 10.1007/978-1-4471-5547-8_72] [Reference Citation Analysis]
|
| 354 |
Gill JS. Posttransplantation Monitoring and Outcomes. National Kidney Foundation Primer on Kidney Diseases 2014. [DOI: 10.1016/b978-1-4557-4617-0.00062-5] [Reference Citation Analysis]
|
| 355 |
Braza F, Degauque N, Soulillou J, Brouard S. Biomarkers of Tolerance in Renal Transplantation. Regenerative Medicine Applications in Organ Transplantation 2014. [DOI: 10.1016/b978-0-12-398523-1.00065-3] [Reference Citation Analysis]
|
| 356 |
Mühlfeld A. Nierentransplantation: Chronische Transplantatschädigung. SpringerReference Innere Medizin 2014. [DOI: 10.1007/978-3-642-54676-1_90-1] [Reference Citation Analysis]
|
| 357 |
Bahous SA, Korjian S, Daaboul Y, Blacher J, Safar ME. Arterial Changes in Renal Transplantation. Blood Pressure and Arterial Wall Mechanics in Cardiovascular Diseases 2014. [DOI: 10.1007/978-1-4471-5198-2_28] [Reference Citation Analysis]
|
| 358 |
Ball S, Dallman MJ. Immunology of Graft Rejection. Kidney Transplantation–Principles and Practice 2014. [DOI: 10.1016/b978-1-4557-4096-3.00002-7] [Reference Citation Analysis]
|
| 359 |
Farris AB, Cornell LD, Colvin RB. Pathology of Kidney Transplantation. Kidney Transplantation–Principles and Practice 2014. [DOI: 10.1016/b978-1-4557-4096-3.00026-x] [Reference Citation Analysis]
|
| 360 |
Gaston RS. Mycophenolates. Kidney Transplantation–Principles and Practice 2014. [DOI: 10.1016/b978-1-4557-4096-3.00018-0] [Reference Citation Analysis]
|
| 361 |
Charif R, Galliford J, Game D, Mclean A. Management of the Acute Transplant. Practical Nephrology 2014. [DOI: 10.1007/978-1-4471-5547-8_69] [Reference Citation Analysis]
|
| 362 |
Josephson MA. Late kidney dysfunction in a kidney transplant recipient. Clin J Am Soc Nephrol 2014;9:590-7. [PMID: 24370771 DOI: 10.2215/CJN.07390713] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 363 |
Lee J. Use of antioxidants to prevent cyclosporine a toxicity. Toxicol Res 2010;26:163-70. [PMID: 24278520 DOI: 10.5487/TR.2010.26.3.163] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 364 |
Gatault P, Lebranchu Y. Conversion to mTOR-inhibitor-based immunosuppression: which patients and when? Transplant Res 2013;2:S3. [PMID: 24565231 DOI: 10.1186/2047-1440-2-S1-S3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 365 |
Friend PJ. Alemtuzumab induction therapy in solid organ transplantation. Transplant Res 2013;2:S5. [PMID: 24565369 DOI: 10.1186/2047-1440-2-S1-S5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 366 |
Russ GR. Optimising the use of mTOR inhibitors in renal transplantation. Transplant Res 2013;2:S4. [PMID: 24565283 DOI: 10.1186/2047-1440-2-S1-S4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 367 |
Panahi A, Bidaki R, Mirhosseini SM, Mehraban D. Renal allograft nephrectomy: comparison between clinical and pathological diagnosis. Nephrourol Mon 2013;5:1001-4. [PMID: 24693511 DOI: 10.5812/numonthly.10596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 368 |
Moreau A, Varey E, Anegon I, Cuturi MC. Effector mechanisms of rejection. Cold Spring Harb Perspect Med. 2013;3. [PMID: 24186491 DOI: 10.1101/cshperspect.a015461] [Cited by in Crossref: 93] [Cited by in F6Publishing: 97] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 369 |
Tan J, Wu YM, Ma B, Pang HL, Tian JH, Jiang L, Bai ZG, Li Y. FTY720 immunosuppression for kidney transplant recipients. Cochrane Database of Systematic Reviews 2013. [DOI: 10.1002/14651858.cd008010.pub2] [Reference Citation Analysis]
|
| 370 |
Bansal D, Yadav AK, Kumar V, Minz M, Sakhuja V, Jha V. Deferred pre-emptive switch from calcineurin inhibitor to sirolimus leads to improvement in GFR and expansion of T regulatory cell population: a randomized, controlled trial. PLoS One 2013;8:e75591. [PMID: 24146762 DOI: 10.1371/journal.pone.0075591] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 371 |
Caplin B, Veighey K, Mahenderan A, Manook M, Henry J, Nitsch D, Harber M, Dupont P, Wheeler DC, Jones G, Fernando B, Howie AJ, Veitch P. Early changes in scores of chronic damage on transplant kidney protocol biopsies reflect donor characteristics, but not future graft function. Clin Transplant 2013;27:E669-78. [PMID: 24118300 DOI: 10.1111/ctr.12251] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 372 |
Masson P, Henderson L, Chapman JR, Craig JC, Webster AC. Belatacept for kidney transplant recipients. Cochrane Database of Systematic Reviews 2013. [DOI: 10.1002/14651858.cd010699] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 373 |
Takahashi K, Uchida K, Yoshimura N, Takahara S, Teraoka S, Teshima R, Cornu-Artis C, Kobayashi E. Efficacy and safety of concentration-controlled everolimus with reduced-dose cyclosporine in Japanese de novo renal transplant patients: 12-month results. Transplant Res 2013;2:14. [PMID: 23866828 DOI: 10.1186/2047-1440-2-14] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 374 |
Salvadori M, Bertoni E. Is it time to give up with calcineurin inhibitors in kidney transplantation? World J Transplant 2013; 3(2): 7-25 [PMID: 24175203 DOI: 10.5500/wjt.v3.i2.7] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 375 |
Hirose Y, Yasui T, Taguchi K, Fujii Y, Niimi K, Hamamoto S, Okada A, Kubota Y, Kawai N, Itoh Y, Tozawa K, Sasaki S, Kohri K. Oxygen nano-bubble water reduces calcium oxalate deposits and tubular cell injury in ethylene glycol-treated rat kidney. Urolithiasis 2013;41:279-94. [PMID: 23754513 DOI: 10.1007/s00240-013-0576-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 376 |
Sanai FM, Mousa D, Al-Mdani A, Al-Shoail G, Al-Ashgar H, Al Meshari K, Al-Qahtani A, Saadeh M, Bzeizi KI, Aleid H. Safety and efficacy of peginterferon-α2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C. J Hepatol 2013;58:1096-103. [PMID: 23428875 DOI: 10.1016/j.jhep.2013.02.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 377 |
Zheng S, Tasnif Y, Hebert MF, Davis CL, Shitara Y, Calamia JC, Lin YS, Shen DD, Thummel KE. CYP3A5 gene variation influences cyclosporine A metabolite formation and renal cyclosporine disposition. Transplantation 2013;95:821-7. [PMID: 23354298 DOI: 10.1097/TP.0b013e31827e6ad9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 378 |
Marquez E, Sadowski E, Reese S, Vidyasagar A, Artz N, Fain S, Jacobson L, Swain W, Djamali A. Serum HSP27 is associated with medullary perfusion in kidney allografts. J Nephrol 2012;25:1075-80. [PMID: 22383348 DOI: 10.5301/jn.5000099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 379 |
Haynes R, Baigent C, Harden P, Landray M, Akyol M, Asderakis A, Baxter A, Bhandari S, Chowdhury P, Clancy M, Emberson J, Gibbs P, Hammad A, Herrington W, Jayne K, Jones G, Krishnan N, Lay M, Lewis D, Macdougall I, Nathan C, Neuberger J, Newstead C, Pararajasingam R, Puliatti C, Rigg K, Rowe P, Sharif A, Sheerin N, Sinha S, Watson C, Friend P; 3C Study Collaborative Group. Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol. Transplant Res 2013;2:7. [PMID: 23641902 DOI: 10.1186/2047-1440-2-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 380 |
Grenier N, Gennisson J, Cornelis F, Le Bras Y, Couzi L. Élastographie rénale par ultrasons. Journal de Radiologie Diagnostique et Interventionnelle 2013;94:560-566. [DOI: 10.1016/j.jradio.2013.01.008] [Reference Citation Analysis]
|
| 381 |
Feldkamp T, Linkermann A. Immunsuppressive Therapie nach Nierentransplantation. Nephrologe 2013;8:217-225. [DOI: 10.1007/s11560-012-0713-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 382 |
Lee H, Park JB, Lee S, Baek S, Kim H, Kim SJ. Intra-osseous injection of donor mesenchymal stem cell (MSC) into the bone marrow in living donor kidney transplantation; a pilot study. J Transl Med 2013;11:96. [PMID: 23578110 DOI: 10.1186/1479-5876-11-96] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 383 |
Arias M, Hernandez D, Guirado L, Campistol JM, Sanchez Plumed JA, Gomez E, Gentil MA, de Santiago C. Clinical profile and post-transplant anaemia in renal transplant recipients restarting dialysis after a failed graft: changing trends between 2001 and 2009. Clinical Kidney Journal 2013;6:156-163. [DOI: 10.1093/ckj/sfs181] [Reference Citation Analysis]
|
| 384 |
Schneeberger S, Gorantla VS, Brandacher G, Zeevi A, Demetris AJ, Lunz JG, Metes DM, Donnenberg AD, Shores JT, Dimartini AF, Kiss JE, Imbriglia JE, Azari K, Goitz RJ, Manders EK, Nguyen VT, Cooney DS, Wachtman GS, Keith JD, Fletcher DR, Macedo C, Planinsic R, Losee JE, Shapiro R, Starzl TE, Lee WP. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg 2013;257:345-51. [PMID: 23001085 DOI: 10.1097/SLA.0b013e31826d90bb] [Cited by in Crossref: 150] [Cited by in F6Publishing: 160] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 385 |
Kaabak MM, Babenko NN, Samsonov DV, Sandrikov VA, Maschan AA, Zokoev AK. Alemtuzumab induction in pediatric kidney transplantation. Pediatr Transplant 2013;17:168-78. [PMID: 23442101 DOI: 10.1111/petr.12048] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 386 |
Israni AK, Leduc R, Jacobson PA, Wildebush W, Guan W, Schladt D, Matas AJ, Oetting WS; DeKAF Genomics Investigators. Inflammation in the setting of chronic allograft dysfunction post-kidney transplant: phenotype and genotype. Clin Transplant 2013;27:348-58. [PMID: 23350966 DOI: 10.1111/ctr.12074] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 387 |
Ibrahim HN, Jackson S, Connaire J, Matas A, Ney A, Najafian B, West A, Lentsch N, Ericksen J, Bodner J, Kasiske B, Mauer M. Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol 2013;24:320-7. [PMID: 23308016 DOI: 10.1681/ASN.2012080777] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 388 |
Reinhold SW, Scherl T, Stölcker B, Bergler T, Hoffmann U, Weingart C, Banas MC, Kollins D, Kammerl MC, Krüger B, Kaess B, Krämer BK, Banas B. Lipoxygenase products in the urine correlate with renal function and body temperature but not with acute transplant rejection. Lipids 2013;48:167-75. [PMID: 23275077 DOI: 10.1007/s11745-012-3751-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 389 |
Lorenzen JM, Martino F, Scheffner I, Bröcker V, Leitolf H, Haller H, Gwinner W. Fetuin, matrix-Gla protein and osteopontin in calcification of renal allografts. PLoS One 2012;7:e52039. [PMID: 23284864 DOI: 10.1371/journal.pone.0052039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 390 |
Ciancio G, Sageshima J, Chen L, Gaynor JJ, Hanson L, Tueros L, Montenora-Velarde E, Gomez C, Kupin W, Guerra G, Mattiazzi A, Fornoni A, Pugliese A, Roth D, Wolf M, Burke GW 3rd. Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years. Am J Transplant 2012;12:3363-76. [PMID: 22946986 DOI: 10.1111/j.1600-6143.2012.04235.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 391 |
Neri L, McEwan P, Sennfält K, Baboolal K. Characterizing the relationship between health utility and renal function after kidney transplantation in UK and US: a cross-sectional study. Health Qual Life Outcomes 2012;10:139. [PMID: 23173709 DOI: 10.1186/1477-7525-10-139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 392 |
Bohra R, Klepacki J, Klawitter J, Klawitter J, Thurman JM, Christians U. Proteomics and metabolomics in renal transplantation-quo vadis? Transpl Int. 2013;26:225-241. [PMID: 23350848 DOI: 10.1111/tri.12003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 393 |
Wojciechowski D, Vincenti F. Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update. Biologics 2012;6:385-93. [PMID: 23152668 DOI: 10.2147/BTT.S23561] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 394 |
Bohra R, Schöning W, Klawitter J, Brunner N, Schmitz V, Shokati T, Lawrence R, Arbelaez MF, Schniedewind B, Christians U, Klawitter J. Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat. PLoS One 2012;7:e48063. [PMID: 23118926 DOI: 10.1371/journal.pone.0048063] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 395 |
O’Riordan E, Orlova TN, Mendelev N, Patschan D, Kemp R, Chander PN, Hu R, Hao G, Gross SS, Iozzo RV. Urinary proteomic analysis of chronic allograft nephropathy. Proteomics Clin Appl. 2008;2:1025-1035. [PMID: 21136903 DOI: 10.1002/prca.200780137] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 396 |
Melvin G, Sandhiya S, Subraja K. Belatacept: A worthy alternative to cyclosporine? J Pharmacol Pharmacother 2012;3:90-2. [PMID: 22368437 DOI: 10.4103/0976-500X.92499] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 397 |
Naesens M, Salvatierra O, Benfield M, Ettenger RB, Dharnidharka V, Harmon W, Mathias R, Sarwal MM; SNS01-NIH-CCTPT Multicenter Trial. Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation. Am J Transplant 2012;12:2730-43. [PMID: 22694733 DOI: 10.1111/j.1600-6143.2012.04144.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 398 |
Moulin B, Merville P, Renaudin K, Buob D, Ferlicot S, Delahousse M, Dantal J, Albano L, Barbet C, Mourad G, Noel LH. Evaluation of protocol biopsy utility 12 months after renal transplantation: a multicenter observational analysis. J Transplant 2012;2012:781263. [PMID: 22988484 DOI: 10.1155/2012/781263] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 399 |
Page EK, Page AJ, Kwun J, Gibby AC, Leopardi F, Jenkins JB, Strobert EA, Song M, Hennigar RA, Iwakoshi N, Knechtle SJ. Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques. Am J Transplant 2012;12:2395-405. [PMID: 22776408 DOI: 10.1111/j.1600-6143.2012.04074.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 400 |
Alberu J, Vargas-Rojas MI, Morales-Buenrostro LE, Crispin JC, Rodríguez-Romo R, Uribe-Uribe NO, Carrasco G, Gómez-Martín D, Alcocer-Varela J. De Novo Donor-Specific HLA Antibody Development and Peripheral CD4(+)CD25(high) Cells in Kidney Transplant Recipients: A Place for Interaction? J Transplant 2012;2012:302539. [PMID: 22970343 DOI: 10.1155/2012/302539] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 401 |
Reischig T, Hribova P, Jindra P, Hes O, Bouda M, Treska V, Viklicky O. Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation. J Am Soc Nephrol 2012;23:1588-97. [PMID: 22917575 DOI: 10.1681/ASN.2012010100] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 402 |
Wu H, Noordmans GA, O'Brien MR, Ma J, Zhao CY, Zhang GY, Kwan TK, Alexander SI, Chadban SJ. Absence of MyD88 signaling induces donor-specific kidney allograft tolerance. J Am Soc Nephrol 2012;23:1701-16. [PMID: 22878960 DOI: 10.1681/ASN.2012010052] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 403 |
Singh S, Watt KD. Long-term medical management of the liver transplant recipient: what the primary care physician needs to know. Mayo Clin Proc 2012;87:779-90. [PMID: 22763347 DOI: 10.1016/j.mayocp.2012.02.021] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 404 |
Djamali A, Reese S, Hafez O, Vidyasagar A, Jacobson L, Swain W, Kolehmainen C, Huang L, Wilson NA, Torrealba JR. Nox2 is a mediator of chronic CsA nephrotoxicity. Am J Transplant 2012;12:1997-2007. [PMID: 22568654 DOI: 10.1111/j.1600-6143.2012.04081.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 405 |
Lowe M, Badell IR, Thompson P, Martin B, Leopardi F, Strobert E, Price AA, Abdulkerim HS, Wang R, Iwakoshi NN, Adams AB, Kirk AD, Larsen CP, Reimann KA. A novel monoclonal antibody to CD40 prolongs islet allograft survival. Am J Transplant 2012;12:2079-87. [PMID: 22845909 DOI: 10.1111/j.1600-6143.2012.04054.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 406 |
Braun H, Schmidt BM, Raiss M, Baisantry A, Mircea-Constantin D, Wang S, Gross ML, Serrano M, Schmitt R, Melk A. Cellular senescence limits regenerative capacity and allograft survival. J Am Soc Nephrol 2012;23:1467-73. [PMID: 22797186 DOI: 10.1681/ASN.2011100967] [Cited by in Crossref: 120] [Cited by in F6Publishing: 123] [Article Influence: 10.9] [Reference Citation Analysis]
|
| 407 |
de Vries DK, Schaapherder AF, Reinders ME. Mesenchymal stromal cells in renal ischemia/reperfusion injury. Front Immunol 2012;3:162. [PMID: 22783252 DOI: 10.3389/fimmu.2012.00162] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 408 |
Luo L, Sun Z, Wu W, Luo G. Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy. BMC Nephrol 2012;13:53. [PMID: 22747784 DOI: 10.1186/1471-2369-13-53] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 409 |
Huber TB, Edelstein CL, Hartleben B, Inoki K, Jiang M, Koya D, Kume S, Lieberthal W, Pallet N, Quiroga A, Ravichandran K, Susztak K, Yoshida S, Dong Z. Emerging role of autophagy in kidney function, diseases and aging. Autophagy 2012;8:1009-31. [PMID: 22692002 DOI: 10.4161/auto.19821] [Cited by in Crossref: 185] [Cited by in F6Publishing: 194] [Article Influence: 16.8] [Reference Citation Analysis]
|
| 410 |
Oh C, Ha JW, Kim YH, Kim Y, Kim YS. Safety and Efficacy of the Early Introduction of Everolimus (CerticanⓇ) with Low Dose of Cyclosporine in de Novo Kidney Recipients after 1 Month of Transplantation (Preliminary Results). Korean J Transplant 2012;26:83-91. [DOI: 10.4285/jkstn.2012.26.2.83] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 411 |
Ramachandran R, Dheerendra PC, Kumar V, Sakhuja V, Jha V, Kohli HS, Rathi M. Maintenance therapy with tacrolimus in lupus nephritis. Lupus 2012;21:1258. [PMID: 22740426 DOI: 10.1177/0961203312451508] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 412 |
Ekberg H, Johansson ME. Challenges and considerations in diagnosing the kidney disease in deteriorating graft function. Transpl Int 2012;25:1119-28. [PMID: 22738034 DOI: 10.1111/j.1432-2277.2012.01516.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 413 |
Birdwell KA, Grady B, Choi L, Xu H, Bian A, Denny JC, Jiang M, Vranic G, Basford M, Cowan JD, Richardson DM, Robinson MP, Ikizler TA, Ritchie MD, Stein CM, Haas DW. The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients. Pharmacogenet Genomics 2012;22:32-42. [PMID: 22108237 DOI: 10.1097/FPC.0b013e32834e1641] [Cited by in Crossref: 81] [Cited by in F6Publishing: 86] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 414 |
Issa N, Kukla A, Ibrahim HN. The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors. Arab J Urol 2012;10:169-74. [PMID: 26558021 DOI: 10.1016/j.aju.2012.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 415 |
Miettinen J, Peräsaari J, Lauronen J, Qvist E, Valta H, Pakarinen M, Merenmies J, Jalanko H. Donor-specific HLA antibodies and graft function in children after renal transplantation. Pediatr Nephrol 2012;27:1011-9. [PMID: 21993970 DOI: 10.1007/s00467-012-2101-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 416 |
Syversveen T, Midtvedt K, Berstad AE, Brabrand K, Strøm EH, Abildgaard A. Tissue elasticity estimated by acoustic radiation force impulse quantification depends on the applied transducer force: an experimental study in kidney transplant patients. Eur Radiol. 2012;22:2130-2137. [PMID: 22610533 DOI: 10.1007/s00330-012-2476-4] [Cited by in Crossref: 82] [Cited by in F6Publishing: 67] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 417 |
Grenier N, Poulain S, Lepreux S, Gennisson JL, Dallaudière B, Lebras Y, Bavu E, Servais A, Meas-Yedid V, Piccoli M. Quantitative elastography of renal transplants using supersonic shear imaging: a pilot study. Eur Radiol. 2012;22:2138-2146. [PMID: 22588518 DOI: 10.1007/s00330-012-2471-9] [Cited by in Crossref: 86] [Cited by in F6Publishing: 90] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 418 |
Birk PE. Surveillance biopsies in children post-kidney transplant. Pediatr Nephrol 2012;27:753-60. [PMID: 21792611 DOI: 10.1007/s00467-011-1969-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 419 |
Pereira AB, Teixeira AL, Rezende NA, Pereira RM, Miranda DM, Oliveira EA, Teixeira MM, Simões E Silva AC. Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: a prospective study. Int Urol Nephrol 2012;44:1539-48. [PMID: 22544449 DOI: 10.1007/s11255-012-0176-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 420 |
Loupy A, Hill GS, Jordan SC. The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol. 2012;8:348-357. [PMID: 22508180 DOI: 10.1038/nrneph.2012.81] [Cited by in Crossref: 262] [Cited by in F6Publishing: 274] [Article Influence: 23.8] [Reference Citation Analysis]
|
| 421 |
Chiasson VL, Jones KA, Kopriva SE, Mahajan A, Young KJ, Mitchell BM. Endothelial cell transforming growth factor-β receptor activation causes tacrolimus-induced renal arteriolar hyalinosis. Kidney Int 2012;82:857-66. [PMID: 22495293 DOI: 10.1038/ki.2012.104] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 422 |
Mathes DW, Hwang B, Graves SS, Edwards J, Chang J, Storer BE, Butts-Miwongtum T, Sale GE, Nash RA, Storb R. Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras. Transplantation 2011;92:1301-8. [PMID: 22082819 DOI: 10.1097/TP.0b013e318237d6d4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 423 |
Hong T, Zhang M, Fan J. Cordyceps sinensis(a traditional Chinese medicine) for kidney transplant recipients. Cochrane Database of Systematic Reviews 2012. [DOI: 10.1002/14651858.cd009698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 424 |
Kurdián M, Herrero-Fresneda I, Lloberas N, Gimenez-Bonafe P, Coria V, Grande MT, Boggia J, Malacrida L, Torras J, Arévalo MA. Delayed mTOR inhibition with low dose of everolimus reduces TGFβ expression, attenuates proteinuria and renal damage in the renal mass reduction model. PLoS One. 2012;7:e32516. [PMID: 22427849 DOI: 10.1371/journal.pone.0032516] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 425 |
Cortazar F, Molnar MZ, Isakova T, Czira ME, Kovesdy CP, Roth D, Mucsi I, Wolf M. Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin. Am J Transplant 2012;12:379-87. [PMID: 22054244 DOI: 10.1111/j.1600-6143.2011.03826.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 426 |
Chhabra D, Skaro AI, Leventhal JR, Dalal P, Shah G, Wang E, Gallon L. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Clin J Am Soc Nephrol 2012;7:504-12. [PMID: 22282478 DOI: 10.2215/CJN.06940711] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 427 |
Ozaki KS, Kimura S, Nalesnik MA, Sico RM, Zhang M, Ueki S, Ross MA, Stolz DB, Murase N. The loss of renal dendritic cells and activation of host adaptive immunity are long-term effects of ischemia/reperfusion injury following syngeneic kidney transplantation. Kidney Int 2012;81:1015-25. [PMID: 22278023 DOI: 10.1038/ki.2011.458] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 428 |
Williams WW, Taheri D, Tolkoff-Rubin N, Colvin RB. Clinical role of the renal transplant biopsy. Nat Rev Nephrol. 2012;8:110-121. [PMID: 22231130 DOI: 10.1038/nrneph.2011.213] [Cited by in Crossref: 98] [Cited by in F6Publishing: 103] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 429 |
Tan JC, Busque S, Scandling JD. Clinical Management. Brenner and Rector's The Kidney 2012. [DOI: 10.1016/b978-1-4160-6193-9.10072-7] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 430 |
Serón D. Introduction: proteinuria in renal transplant patients. Transplant Rev (Orlando) 2012;26:1-2. [PMID: 22137725 DOI: 10.1016/j.trre.2011.10.005] [Reference Citation Analysis]
|
| 431 |
Roussey-Kesler G, Decramer S. [Outcomes of pediatric renal transplantation in France]. Nephrol Ther 2011;7:611-7. [PMID: 22118792 DOI: 10.1016/j.nephro.2011.11.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 432 |
Luan FL, Kommareddi M, Cibrik DM, Samaniego M, Ojo AO. The time interval between kidney and pancreas transplantation and the clinical outcomes of pancreas after kidney transplantation. Clin Transplant 2012;26:403-10. [PMID: 22003873 DOI: 10.1111/j.1399-0012.2011.01519.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 433 |
Cowan ML, Sciammas R, Chong AS. Experimental models of B cell tolerance in transplantation. Semin Immunol 2012;24:77-85. [PMID: 21925896 DOI: 10.1016/j.smim.2011.08.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 434 |
Vodenik B, Rovira J, Diekmann F, Revuelta I, Oppenheimer F, Campistol JM. Preemptive use of Mammalian target of rapamycin inhibitors in living donor transplantation. Transplant Proc 2011;43:2568-73. [PMID: 21911124 DOI: 10.1016/j.transproceed.2011.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 435 |
Matas AJ. Calcineurin inhibitors: short-term friend, long-term foe? Clin Pharmacol Ther 2011;90:209-11. [PMID: 21772297 DOI: 10.1038/clpt.2011.77] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 436 |
Naesens M, Khatri P, Li L, Sigdel TK, Vitalone MJ, Chen R, Butte AJ, Salvatierra O, Sarwal MM. Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int. 2011;80:1364-1376. [PMID: 21881554 DOI: 10.1038/ki.2011.245] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 437 |
Ma Y, Jiang W, Liu Q, Ryuko S, Kuno T. Genome-wide screening for genes associated with FK506 sensitivity in fission yeast. PLoS One 2011;6:e23422. [PMID: 21850271 DOI: 10.1371/journal.pone.0023422] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 438 |
Guerra G, Ciancio G, Gaynor JJ, Zarak A, Brown R, Hanson L, Sageshima J, Roth D, Chen L, Kupin W. Randomized trial of immunosuppressive regimens in renal transplantation. J Am Soc Nephrol. 2011;22:1758-1768. [PMID: 21807891 DOI: 10.1681/asn.2011010006] [Cited by in Crossref: 58] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 439 |
Christians U, Klawitter J, Klawitter J, Brunner N, Schmitz V. Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions. Expert Opin Drug Metab Toxicol 2011;7:175-200. [PMID: 21241200 DOI: 10.1517/17425255.2011.544249] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 440 |
de Fijter JW. Tacrolimus dosing in mycophenolate-treated patients--can we get away with less? Transplantation 2011;92:10-1. [PMID: 21654351 DOI: 10.1097/TP.0b013e31821fad43] [Reference Citation Analysis]
|
| 441 |
Höcker B. Histopathologie des Nierentransplantats im Wandel. Nephrologe 2011;6:344-345. [DOI: 10.1007/s11560-011-0552-4] [Reference Citation Analysis]
|
| 442 |
Hazzan M, Hertig A, Buob D, Copin MC, Noël C, Rondeau E, Dubois-Xu YC. Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipients. J Am Soc Nephrol 2011;22:1375-81. [PMID: 21719789 DOI: 10.1681/ASN.2010060673] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 443 |
Messa P, Cafforio C, Alfieri C. Clinical impact of hypercalcemia in kidney transplant. Int J Nephrol 2011;2011:906832. [PMID: 21760999 DOI: 10.4061/2011/906832] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 444 |
Mas VR, Mueller TF, Archer KJ, Maluf DG. Identifying biomarkers as diagnostic tools in kidney transplantation. Expert Rev Mol Diagn. 2011;11:183-196. [PMID: 21405969 DOI: 10.1586/erm.10.119] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 445 |
Stegall MD, Park W, Cosio F. An Important Debate. American Journal of Transplantation 2011;11:1758-1758. [DOI: 10.1111/j.1600-6143.2011.03602.x] [Reference Citation Analysis]
|
| 446 |
Marcén R. Immunosuppression and renal transplant rejection: review of current and emerging therapies. Clinical Investigation 2011;1:859-877. [DOI: 10.4155/cli.11.49] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 447 |
Monaco AP, Morris PJ. Chronic renal allograft damage: not enough immunosuppression? Transplantation 2011;91:S1-3. [PMID: 21519212 DOI: 10.1097/TP.0b013e31821b0f24] [Reference Citation Analysis]
|
| 448 |
Steegh FM, Gelens MA, Nieman FH, van Hooff JP, Cleutjens JP, van Suylen RJ, Daemen MJ, van Heurn EL, Christiaans MH, Peutz-Kootstra CJ. Early loss of peritubular capillaries after kidney transplantation. J Am Soc Nephrol 2011;22:1024-9. [PMID: 21566051 DOI: 10.1681/ASN.2010050531] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 449 |
Dinavahi R, George A, Tretin A, Akalin E, Ames S, Bromberg JS, Deboccardo G, Dipaola N, Lerner SM, Mehrotra A. Antibodies reactive to non-HLA antigens in transplant glomerulopathy. J Am Soc Nephrol. 2011;22:1168-1178. [PMID: 21566057 DOI: 10.1681/asn.2010111183] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 450 |
Snanoudj R, Zuber J, Legendre C. Co-stimulation blockade as a new strategy in kidney transplantation: benefits and limits. Drugs 2010;70:2121-31. [PMID: 20964456 DOI: 10.2165/11538140-000000000-00000] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 451 |
Wang M, Jin Q, Tu H, Mao Y, Yu J, Chen Y, Shou Z, He Q, Wu J, Zheng S. Detection of renal allograft dysfunction with characteristic protein fingerprint by serum proteomic analysis. Int Urol Nephrol. 2011;43:1009-1017. [PMID: 21516471 DOI: 10.1007/s11255-011-9962-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 452 |
Neri L, Dukes J, Brennan DC, Salvalaggio PR, Seelam S, Desiraju S, Schnitzler M. Impaired renal function is associated with worse self-reported outcomes after kidney transplantation. Qual Life Res 2011;20:1689-98. [PMID: 21479956 DOI: 10.1007/s11136-011-9905-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 453 |
Miglio G, Rosa AC, Rattazzi L, Grange C, Collino M, Camussi G, Fantozzi R. The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury. Br J Pharmacol 2011;162:111-25. [PMID: 20840470 DOI: 10.1111/j.1476-5381.2010.01032.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 454 |
Matas AJ. Chronic progressive calcineurin nephrotoxicity: an overstated concept. Am J Transplant 2011;11:687-92. [PMID: 21446973 DOI: 10.1111/j.1600-6143.2011.03505.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 455 |
Hwang E, Jang M, Kwak C, Han S, Park S, Kim H, Kim H, Cho W. The Changes of Graft Survival and Causes of Graft Failure after Kidney Transplantation. Korean J Transplant 2011;25:22-30. [DOI: 10.4285/jkstn.2011.25.1.22] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 456 |
Cheng J, Torkamani A, Grover RK, Jones TM, Ruiz DI, Schork NJ, Quigley MM, Hall FW, Salomon DR, Lerner RA. Ectopic B-cell clusters that infiltrate transplanted human kidneys are clonal. Proc Natl Acad Sci U S A. 2011;108:5560-5565. [PMID: 21415369 DOI: 10.1073/pnas.1101148108] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 457 |
Kendrick EA, Davis CL. Management of the successful solid organ transplant recipient. Primer on Transplantation 2011. [DOI: 10.1002/9781444391770.ch5] [Reference Citation Analysis]
|
| 458 |
Flechner SM. Immunosuppression without calcineurin inhibition: by ZEUS. Lancet 2011;377:788-9. [PMID: 21334739 DOI: 10.1016/S0140-6736(10)62236-2] [Reference Citation Analysis]
|
| 459 |
Coelho VP, Ioschpe R, Caldas C, Spadafora-Ferreira M, Fonseca JA, Cardoso MR, Palacios SA, Kalil J, Goldberg AC. Contrasting roles of donor and recipient TGFB1 and IFNG gene polymorphic variants in chronic kidney transplant rejection. Einstein (Sao Paulo) 2011;9:46-51. [PMID: 26760552 DOI: 10.1590/S1679-45082011AO1852] [Reference Citation Analysis]
|
| 460 |
Höcker B, Tönshoff B. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option? Paediatr Drugs 2011;13:49-69. [PMID: 21162600 DOI: 10.2165/11538530-000000000-00000] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 461 |
Mueller TF, Solez K, Mas V. Assessment of kidney organ quality and prediction of outcome at time of transplantation. Semin Immunopathol. 2011;33:185-199. [PMID: 21274534 DOI: 10.1007/s00281-011-0248-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 462 |
Rubin MF. Hypertension following kidney transplantation. Adv Chronic Kidney Dis 2011;18:17-22. [PMID: 21224026 DOI: 10.1053/j.ackd.2010.10.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 463 |
Maltsev A, Jushinskis J, Rozentals R. The Use of Deceased Donors for Kidneys Transplantations. Acta Chirurgica Latviensis 2011;11. [DOI: 10.2478/v10163-012-0021-9] [Reference Citation Analysis]
|
| 464 |
Thomas G, Nurko S, Srinivas TR. Immunosuppressive Therapy in Kidney and Pancreas Transplantation. Kidney and Pancreas Transplantation 2011. [DOI: 10.1007/978-1-60761-642-9_3] [Reference Citation Analysis]
|
| 465 |
Srinivas TR, Meier-kriesche H, Schold JD. Outcomes of Kidney and Pancreas Transplantation. Kidney and Pancreas Transplantation 2011. [DOI: 10.1007/978-1-60761-642-9_7] [Reference Citation Analysis]
|
| 466 |
Thiem U, Borchhardt K. Vitamin D in solid organ transplantation with special emphasis on kidney transplantation. Vitam Horm 2011;86:429-68. [PMID: 21419283 DOI: 10.1016/B978-0-12-386960-9.00019-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 467 |
Wojciechowski D, Vincenti F. New targets for immunosuppression in kidney transplantation: Focus on recent clinical trials. Dial Transplant 2011;40:18-22. [DOI: 10.1002/dat.20528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 468 |
Weir MR. Can the early elimination of calcineurin inhibitors result in clinical benefits? Transplant Proc 2010;42:S16-20. [PMID: 21095444 DOI: 10.1016/j.transproceed.2010.07.005] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 469 |
Gupta G, Womer KL. Profile of belatacept and its potential role in prevention of graft rejection following renal transplantation. Drug Des Devel Ther. 2010;4:375-382. [PMID: 21151624 DOI: 10.2147/dddt.s10432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 470 |
Racapé M, Soulillou JP, Brouard S. [Transcriptomic profiling in renal transplantation: characterization of the graft status]. Med Sci (Paris) 2010;26:909-11. [PMID: 21106169 DOI: 10.1051/medsci/20102611909] [Reference Citation Analysis]
|
| 471 |
Mujtaba MA, Taber TE, Goggins WC, Yaqub MS, Mishler DP, Milgrom ML, Fridell JA, Lobashevsky A, Powelson JA, Sharfuddin AA. Early steroid withdrawal in repeat kidney transplantation. Clin J Am Soc Nephrol. 2011;6:404-411. [PMID: 21051751 DOI: 10.2215/cjn.05110610] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 472 |
Rostaing L, Massari P, Garcia VD, Mancilla-Urrea E, Nainan G, del Carmen Rial M, Steinberg S, Vincenti F, Shi R, Di Russo G. Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study. Clin J Am Soc Nephrol. 2011;6:430-439. [PMID: 21051752 DOI: 10.2215/cjn.05840710] [Cited by in Crossref: 139] [Cited by in F6Publishing: 144] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 473 |
Grigoryev YA, Kurian SM, Avnur Z, Borie D, Deng J, Campbell D, Sung J, Nikolcheva T, Quinn A, Schulman H, Peng SL, Schaffer R, Fisher J, Mondala T, Head S, Flechner SM, Kantor AB, Marsh C, Salomon DR. Deconvoluting post-transplant immunity: cell subset-specific mapping reveals pathways for activation and expansion of memory T, monocytes and B cells. PLoS One 2010;5:e13358. [PMID: 20976225 DOI: 10.1371/journal.pone.0013358] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 474 |
Van Gurp E, Bustamante J, Franco A, Rostaing L, Becker T, Rondeau E, Czajkowski Z, Rydzewski A, Alarcon A, Bachleda P, Samlik J, Burmeister D, Pallardo L, Moal MC, Rutkowski B, Wlodarczyk Z. Comparable Renal Function at 6 Months with Tacrolimus Combined with Fixed-Dose Sirolimus or MMF: Results of a Randomized Multicenter Trial in Renal Transplantation. J Transplant 2010;2010:731426. [PMID: 20953372 DOI: 10.1155/2010/731426] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 475 |
Park WD, Griffin MD, Cornell LD, Cosio FG, Stegall MD. Fibrosis with inflammation at one year predicts transplant functional decline. J Am Soc Nephrol 2010;21:1987-97. [PMID: 20813870 DOI: 10.1681/ASN.2010010049] [Cited by in Crossref: 165] [Cited by in F6Publishing: 172] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 476 |
Vervaet BA, Verhulst A, De Broe ME, D'Haese PC. The tubular epithelium in the initiation and course of intratubular nephrocalcinosis. Urol Res 2010;38:249-56. [PMID: 20680256 DOI: 10.1007/s00240-010-0290-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 477 |
Mengel M. Chronische Nierentransplantatschädigung. Nephrologe 2010;5:307-313. [DOI: 10.1007/s11560-010-0415-4] [Reference Citation Analysis]
|
| 478 |
Mas VR, Archer KJ, Scian M, Maluf DG. Molecular pathways involved in loss of graft function in kidney transplant recipients. Expert Rev Mol Diagn 2010;10:269-84. [PMID: 20370585 DOI: 10.1586/erm.10.6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 479 |
Gorantla VS, Schneeberger S, Brandacher G, Sucher R, Zhang D, Lee WP, Zheng XX. T regulatory cells and transplantation tolerance. Transplant Rev (Orlando) 2010;24:147-59. [PMID: 20541385 DOI: 10.1016/j.trre.2010.04.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 480 |
Guirado L, Ruiz JC, Andres A, Rengel M, Escuin F, Ortega F, Romero R, Diaz JM, Beneyto I, Morales JM, For the Spanish Group of Study of Chronic Allograft Nephropathy. Results of renal re-transplant in Spain (1990-2002). Clinical Kidney Journal 2010;3:ii37-ii40. [DOI: 10.1093/ndtplus/sfq069] [Reference Citation Analysis]
|
| 481 |
Einecke G, Reeve J, Sis B, Mengel M, Hidalgo L, Famulski KS, Matas A, Kasiske B, Kaplan B, Halloran PF. A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest 2010;120:1862-72. [PMID: 20501945 DOI: 10.1172/JCI41789] [Cited by in Crossref: 151] [Cited by in F6Publishing: 158] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 482 |
Schröppel B, Heeger PS. Gazing into a crystal ball to predict kidney transplant outcome. J Clin Invest 2010;120:1803-6. [PMID: 20501950 DOI: 10.1172/JCI43286] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 483 |
Newell KA, Asare A, Kirk AD, Gisler TD, Bourcier K, Suthanthiran M, Burlingham WJ, Marks WH, Sanz I, Lechler RI, Hernandez-Fuentes MP, Turka LA, Seyfert-Margolis VL; Immune Tolerance Network ST507 Study Group. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010;120:1836-47. [PMID: 20501946 DOI: 10.1172/JCI39933] [Cited by in Crossref: 523] [Cited by in F6Publishing: 556] [Article Influence: 40.2] [Reference Citation Analysis]
|
| 484 |
Nadig SN, Wieckiewicz J, Wu DC, Warnecke G, Zhang W, Luo S, Schiopu A, Taggart DP, Wood KJ. In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med. 2010;16:809-813. [PMID: 20473306 DOI: 10.1038/nm.2154] [Cited by in Crossref: 235] [Cited by in F6Publishing: 250] [Article Influence: 18.1] [Reference Citation Analysis]
|
| 485 |
Bolinger B, Engeler D, Krebs P, Miller S, Firner S, Hoffmann M, Palmer DC, Restifo NP, Tian Y, Clavien PA, Ludewig B. IFN-gamma-receptor signaling ameliorates transplant vasculopathy through attenuation of CD8+ T-cell-mediated injury of vascular endothelial cells. Eur J Immunol 2010;40:733-43. [PMID: 20049875 DOI: 10.1002/eji.200939706] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 486 |
Alarrayed SM, El-Agroudy AE, Alarrayed AS, Al Ghareeb SM, Garadah TS, El-Sharqawi SY, Al-Aradi AH, Dandi BG, Abdulla S. Sirolimus-based calcineurin inhibitor withdrawal immunosuppressive regimen in kidney transplantation: a single center experience. Clin Exp Nephrol. 2010;14:248-255. [PMID: 20232105 DOI: 10.1007/s10157-010-0269-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 487 |
Bodonyi-Kovacs G, Putheti P, Marino M, Avihingsanon Y, Uknis ME, Monaco AP, Strom TB, Pavlakis M. Gene expression profiling of the donor kidney at the time of transplantation predicts clinical outcomes 2 years after transplantation. Hum Immunol. 2010;71:451-455. [PMID: 20156509 DOI: 10.1016/j.humimm.2010.02.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 488 |
Morath C, Zeier M, Sommerer C. Immunsuppression nach Nierentransplantation. Nephrologe 2010;5:108-117. [DOI: 10.1007/s11560-009-0370-0] [Reference Citation Analysis]
|
| 489 |
Juan Alberto Fierro C. Monitoreo inmunológico: el comienzo de una nueva era en trasplantes. Revista Médica Clínica Las Condes 2010;21:227-237. [DOI: 10.1016/s0716-8640(10)70529-0] [Reference Citation Analysis]
|
| 490 |
Bondar' IA, Klimontov VV. Treatment of patients with diabetes mellitus following kidney transplantation. Probl Endokrinol (Mosk) 2010;56:42-47. [DOI: 10.14341/probl201056142-47] [Reference Citation Analysis]
|
| 491 |
Hueso M, Navarro E, Moreso F, O'Valle F, Pérez-Riba M, Del Moral RG, Grinyó JM, Serón D. Intragraft expression of the IL-10 gene is up-regulated in renal protocol biopsies with early interstitial fibrosis, tubular atrophy, and subclinical rejection. Am J Pathol 2010;176:1696-704. [PMID: 20150436 DOI: 10.2353/ajpath.2010.090411] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 492 |
Ling XB, Sigdel TK, Lau K, Ying L, Lau I, Schilling J, Sarwal MM. Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J Am Soc Nephrol. 2010;21:646-653. [PMID: 20150539 DOI: 10.1681/asn.2009080876] [Cited by in Crossref: 104] [Cited by in F6Publishing: 105] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 493 |
Höcker B, Tönshoff B. Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview. Paediatr Drugs 2009;11:381-96. [PMID: 19877724 DOI: 10.2165/11316100-000000000-00000] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 494 |
Caillard S. [Benefits of proliferation signal inhibitors beyond immunosuppression. Vascular protection and experience in heart transplantation]. Nephrol Ther 2009;5 Suppl 6:S379-84. [PMID: 20129449 DOI: 10.1016/S1769-7255(09)73429-7] [Reference Citation Analysis]
|
| 495 |
Nakorchevsky A, Hewel JA, Kurian SM, Mondala TS, Campbell D, Head SR, Marsh CL, Yates JR 3rd, Salomon DR. Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. J Am Soc Nephrol 2010;21:362-73. [PMID: 20093355 DOI: 10.1681/ASN.2009060628] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 496 |
Brown KL, Palyvoda OY, Thakur JS, Nehlsen-Cannarella SL, Fagoaga OR, Gruber SA, Auner GW. Differentiation of alloreactive versus CD3/CD28 stimulated T-lymphocytes using Raman spectroscopy: a greater specificity for noninvasive acute renal allograft rejection detection. Cytometry A 2009;75:917-23. [PMID: 19753631 DOI: 10.1002/cyto.a.20797] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 497 |
Goebel J, Defoor W, Sheldon C. PEDIATRIC RENAL TRANSPLANTATION. Pediatric Urology 2010. [DOI: 10.1016/b978-1-4160-3204-5.00047-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 498 |
Wavamunno MD, O’connell PJ. Chronic Allograft Injury. Comprehensive Clinical Nephrology 2010. [DOI: 10.1016/b978-0-323-05876-6.00103-9] [Reference Citation Analysis]
|
| 499 |
Harmon WE. Pediatric Renal Transplantation. Chronic Kidney Disease, Dialysis, and Transplantation 2010. [DOI: 10.1016/b978-1-4377-0987-2.00041-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 500 |
Gaston RS. Evaluation of Renal Allograft Dysfunction. Kidney Transplantation: A Guide to the Care of Kidney Transplant Recipients 2010. [DOI: 10.1007/978-1-4419-1690-7_11] [Reference Citation Analysis]
|
| 501 |
Wiseman AC, Cooper JE. Optimizing Immunosuppression. Kidney Transplantation: A Guide to the Care of Kidney Transplant Recipients 2010. [DOI: 10.1007/978-1-4419-1690-7_10] [Reference Citation Analysis]
|
| 502 |
Weir GC, Gaglia JL. Pancreatic and Islet Transplantation. Endocrinology 2010. [DOI: 10.1016/b978-1-4160-5583-9.00050-2] [Reference Citation Analysis]
|
| 503 |
Sadlier DM, O'meara YM. Recurrent and De Novo Renal Diseases After Kidney Transplantation. Chronic Kidney Disease, Dialysis, and Transplantation 2010. [DOI: 10.1016/b978-1-4377-0987-2.00040-6] [Reference Citation Analysis]
|
| 504 |
Bahirwani R, Reddy KR. Outcomes after liver transplantation: chronic kidney disease. Liver Transpl 2009;15 Suppl 2:S70-4. [PMID: 19876956 DOI: 10.1002/lt.21900] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 505 |
Charlton MR, Wall WJ, Ojo AO, Ginès P, Textor S, Shihab FS, Marotta P, Cantarovich M, Eason JD, Wiesner RH, Ramsay MA, Garcia-Valdecasas JC, Neuberger JM, Feng S, Davis CL, Gonwa TA; International Liver Transplantation Society Expert Panel. Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl 2009;15:S1-34. [PMID: 19877213 DOI: 10.1002/lt.21877] [Cited by in Crossref: 114] [Cited by in F6Publishing: 114] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 506 |
Kuypers DR. Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions. Drugs Aging 2009;26:715-37. [PMID: 19728747 DOI: 10.2165/11316480-000000000-00000] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 507 |
Tan JY, Wu YM, Yang KH, Ma B, Pang HL, Tian JH, Jiang L, Bai ZG, Li Y. FTY720 immunosuppression for kidney transplant recipients. Cochrane Database of Systematic Reviews 2009. [DOI: 10.1002/14651858.cd008010] [Reference Citation Analysis]
|
| 508 |
Jankowska-Gan E, Sollinger HW, Pirsch JD, Cai J, Pascual J, Haynes LD, Munoz del Rio A, Burlingham WJ. Successful reduction of immunosuppression in older renal transplant recipients who exhibit donor-specific regulation. Transplantation 2009;88:533-41. [PMID: 19696637 DOI: 10.1097/TP.0b013e3181b0f92f] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 509 |
Naesens M, Lerut E, de Jonge H, Van Damme B, Vanrenterghem Y, Kuypers DR. Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts. J Am Soc Nephrol. 2009;20:2468-2480. [PMID: 19762492 DOI: 10.1681/asn.2009020192] [Cited by in Crossref: 108] [Cited by in F6Publishing: 116] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 510 |
Meier-Kriesche HU, Schold JD, Vanrenterghem Y, Halloran PF, Ekberg H. Uric acid levels have no significant effect on renal function in adult renal transplant recipients: evidence from the symphony study. Clin J Am Soc Nephrol. 2009;4:1655-1660. [PMID: 19713295 DOI: 10.2215/cjn.02700409] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 511 |
Russ G. Where did we leave off in 2008? Conclusions from the 8th International Symposium. Transplant Proc 2009;41:S27-30. [PMID: 19651292 DOI: 10.1016/j.transproceed.2009.06.094] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 512 |
Poommipanit NB, Bunnapradist S. CNI Sparing: Short-Term Results Promising, but Long-Term Data Needed. Nephrology Times 2009;2:6-10. [DOI: 10.1097/01.nep.0000359448.89518.c0] [Reference Citation Analysis]
|
| 513 |
Li C, Yang CW. The pathogenesis and treatment of chronic allograft nephropathy. Nat Rev Nephrol. 2009;5:513-519. [PMID: 19636333 DOI: 10.1038/nrneph.2009.113] [Cited by in Crossref: 93] [Cited by in F6Publishing: 99] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 514 |
Frimat L, Cridlig J, Thilly N, Kessler M. [Medical care of chronic kidney disease after kidney transplantation]. Nephrol Ther 2009;5 Suppl 4:S293-6. [PMID: 19596352 DOI: 10.1016/S1769-7255(09)74562-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 515 |
Kurian SM, Heilman R, Mondala TS, Nakorchevsky A, Hewel JA, Campbell D, Robison EH, Wang L, Lin W, Gaber L. Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. PLoS One. 2009;4:e6212. [PMID: 19593431 DOI: 10.1371/journal.pone.0006212] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 516 |
Li J, Liu B, Yan LN, Wang LL, Lau WY, Li B, Wang WT, Xu MQ, Yang JY, Li FG. Microproteinuria for detecting calcineurin inhibitor-related nephrotoxicity after liver transplantation. World J Gastroenterol 2009; 15(23): 2913-2917 [PMID: 19533816 DOI: 10.3748/wjg.15.2913] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 517 |
Yoon HE, Yang CW. Established and newly proposed mechanisms of chronic cyclosporine nephropathy. Korean J Intern Med 2009;24:81-92. [PMID: 19543484 DOI: 10.3904/kjim.2009.24.2.81] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 518 |
Ding Z, Chen Z, Chen X, Cai M, Guo H, Gong N. Adenovirus-mediated antisense ERK2 gene therapy ameliorates chronic allograft nephropathy in a rat model. Front Med China 2009;3:204-210. [DOI: 10.1007/s11684-009-0039-0] [Reference Citation Analysis]
|
| 519 |
Golshayan D, Pascual M, Vogt B. Mycophenolic acid formulations in adult renal transplantation - update on efficacy and tolerability. Ther Clin Risk Manag 2009;5:341-51. [PMID: 19753127 DOI: 10.2147/tcrm.s3496] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 520 |
Becker S, Witzke O. Management der Immunsuppression nach Nierentransplantation. Nephrologe 2009;4:221-229. [DOI: 10.1007/s11560-008-0274-4] [Reference Citation Analysis]
|
| 521 |
Quintana LF, Campistol JM, Alcolea MP, Bañon-Maneus E, Sol-González A, Cutillas PR. Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol Cell Proteomics 2009;8:1658-73. [PMID: 19357086 DOI: 10.1074/mcp.M900059-MCP200] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 522 |
Huh KH, Ahn HJ, Park J, Ju MK, Song JS, Kim MS, Kim SI, Kim YS. Mycophenolic acid inhibits oleic acid-induced mesangial cell activation through both cellular reactive oxygen species and inosine monophosphate dehydrogenase 2 pathways. Pediatr Nephrol 2009;24:737-45. [PMID: 19093139 DOI: 10.1007/s00467-008-1075-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 523 |
. Interactive Joint Scientific Workshop—Treatment Options for Immunosuppression in Different Clinical Scenarios. Hong Kong Journal of Nephrology 2009;11:20-9. [DOI: 10.1016/s1561-5413(09)60005-3] [Reference Citation Analysis]
|
| 524 |
Mannon RB. Post-transplantation Monitoring and Outcomes. Primer on Kidney Diseases 2009. [DOI: 10.1016/b978-1-4160-5185-5.00063-8] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 525 |
Kang NR, Lee JE, Huh W, Kim SJ, Kim YG, Kim DJ, Oh HY. Minimal proteinuria one year after transplant is a risk factor for graft survival in kidney transplantation. J Korean Med Sci 2009;24 Suppl:S129-34. [PMID: 19194542 DOI: 10.3346/jkms.2009.24.S1.S129] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 526 |
Khurana A, Brennan DC. Current Concepts of Immunosuppression and Side Effects. Pathology of Solid Organ Transplantation 2009. [DOI: 10.1007/978-3-540-79343-4_2] [Reference Citation Analysis]
|
| 527 |
Chaballa M, Filicko-o'hara J, Holt D, Frank AM, Wagner JL, Grosso D, Flomenberg N. TRANSPLANT MEDICINE. Pharmacology and Therapeutics 2009. [DOI: 10.1016/b978-1-4160-3291-5.50096-2] [Reference Citation Analysis]
|
| 528 |
Djamali A, Vidyasagar A, Adulla M, Hullett D, Reese S. Nox-2 is a modulator of fibrogenesis in kidney allografts. Am J Transplant 2009;9:74-82. [PMID: 18976289 DOI: 10.1111/j.1600-6143.2008.02463.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 529 |
Fletcher JT, Nankivell BJ, Alexander SI. Chronic allograft nephropathy. Pediatr Nephrol 2009;24:1465-71. [PMID: 18584214 DOI: 10.1007/s00467-008-0869-z] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 530 |
Quintana LF, Solé-Gonzalez A, Kalko SG, Bañon-Maneus E, Solé M, Diekmann F, Gutierrez-Dalmau A, Abian J, Campistol JM. Urine proteomics to detect biomarkers for chronic allograft dysfunction. J Am Soc Nephrol 2009;20:428-35. [PMID: 19056874 DOI: 10.1681/ASN.2007101137] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 531 |
Goebel J. Renal Issues in Organ Transplant Recipients in the PICU. Pediatric Nephrology in the ICU. [DOI: 10.1007/978-3-540-74425-2_18] [Reference Citation Analysis]
|
| 532 |
Pattison J, Sacks S. Long-term tacrolimus versus long-term ciclosporin in renal transplant recipients with poor graft function. Nat Rev Nephrol 2008;4:598-599. [DOI: 10.1038/ncpneph0944] [Reference Citation Analysis]
|
| 533 |
Yilmaz S, Sar A. Pathogenesis and management of chronic allograft nephropathy. Drugs 2008;68 Suppl 1:21-31. [PMID: 18442298 DOI: 10.2165/00003495-200868001-00004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 534 |
Haas M, Segev DL, Racusen LC, Bagnasco SM, Locke JE, Warren DS, Simpkins CE, Lepley D, King KE, Kraus ES, Montgomery RA. C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol. 2009;20:197-204. [PMID: 18776120 DOI: 10.1681/asn.2008030279] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 535 |
Bedi S, Vidyasagar A, Djamali A. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev (Orlando) 2008;22:1-5. [PMID: 18631853 DOI: 10.1016/j.trre.2007.09.004] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 536 |
El-Agroudy AE, El-Dahshan KF, Mahmoud K, Ismail AM, El-Baz M, Shokeir AA, Ghoneim MA. Long-term graft outcome in patients with chronic allograft nephropathy after immunosuppression modifications. Clin Exp Nephrol 2009;13:66-72. [PMID: 18716711 DOI: 10.1007/s10157-008-0077-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 537 |
Feitoza CQ, Gonçalves GM, Semedo P, Cenedeze MA, Pinheiro HS, Beraldo FC, dos Santos OF, Teixeira Vde P, dos Reis MA, Mazzali M, Pacheco-Silva A, Câmara NO. Inhibition of COX 1 and 2 prior to renal ischemia/reperfusion injury decreases the development of fibrosis. Mol Med 2008;14:724-30. [PMID: 18769637 DOI: 10.2119/2008-00064.Feitoza] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 538 |
Maluf DG, Mas VR, Archer KJ, Yanek K, Gibney EM, King AL, Cotterell A, Fisher RA, Posner MP. Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis. Mol Med 2008;14:276-85. [PMID: 18286166 DOI: 10.2119/2007-00111.Maluf] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 539 |
Kreijveld E, Koenen HJ, van Cranenbroek B, van Rijssen E, Joosten I, Hilbrands LB. Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus. PLoS One 2008;3:e2711. [PMID: 18628993 DOI: 10.1371/journal.pone.0002711] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 540 |
Toki D, Ishida H, Horita S, Tokumoto T, Shimizu T, Iizuka J, Tunoyama K, Masumoto K, Shirakawa H, Setoguchi K, Iida S, Tanabe K, Yamaguchi Y. Persistent subclinical rejection associated with nodular B-cell infiltrates in a renal transplant recipient: B-cell infiltrates in subclinical rejection. Clinical Transplantation 2008;22:53-7. [DOI: 10.1111/j.1399-0012.2008.00850.x] [Reference Citation Analysis]
|
| 541 |
Bestard O, Cruzado JM, Rama I, Torras J, Gomà M, Serón D, Moreso F, Gil-Vernet S, Grinyó JM. Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol. 2008;19:2020-2026. [PMID: 18495961 DOI: 10.1681/asn.2007111174] [Cited by in Crossref: 131] [Cited by in F6Publishing: 132] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 542 |
Vitalone MJ, O'Connell PJ, Jimenez-Vera E, Yuksel A, Wavamunno M, Fung CL, Chapman JR, Nankivell BJ. Epithelial-to-mesenchymal transition in early transplant tubulointerstitial damage. J Am Soc Nephrol 2008;19:1571-83. [PMID: 18480317 DOI: 10.1681/ASN.2007050580] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 543 |
Azarpira N, Bagheri M, Raisjalali GA, Aghdaie MH, Behzadi S, Salahi H, Rahsaz M, Darai M, Ashraf MJ, Geramizadeh B. Angiotensinogen, angiotensine converting enzyme and plasminogen activator inhibitor-1 gene polymorphism in chronic allograft dysfunction. Mol Biol Rep 2009;36:909-15. [PMID: 18454324 DOI: 10.1007/s11033-008-9262-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 544 |
Dyer P. Immunology and principles of transplantation. Surgery (Oxford) 2008;26:175-182. [DOI: 10.1016/j.mpsur.2008.03.006] [Reference Citation Analysis]
|
| 545 |
Mengel M. Protokollbiopsie nach Nierentransplantation: Wissenschaftliches Interesse oder notwendige Frühdiagnostik? Nephrologe 2008;3:216-21. [DOI: 10.1007/s11560-008-0148-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 546 |
Hertig A, Anglicheau D, Verine J, Pallet N, Touzot M, Ancel PY, Mesnard L, Brousse N, Baugey E, Glotz D. Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol. 2008;19:1584-1591. [PMID: 18434568 DOI: 10.1681/asn.2007101160] [Cited by in Crossref: 101] [Cited by in F6Publishing: 106] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 547 |
Bestard O, Nickel P, Cruzado JM, Schoenemann C, Boenisch O, Sefrin A, Grinyó JM, Volk HD, Reinke P. Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients. J Am Soc Nephrol 2008;19:1419-29. [PMID: 18417724 DOI: 10.1681/ASN.2007050539] [Cited by in Crossref: 104] [Cited by in F6Publishing: 107] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 548 |
Jevnikar AM, Mannon RB. Late kidney allograft loss: what we know about it, and what we can do about it. Clin J Am Soc Nephrol. 2008;3 Suppl 2:S56-S67. [PMID: 18309004 DOI: 10.2215/cjn.03040707] [Cited by in Crossref: 84] [Cited by in F6Publishing: 91] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 549 |
Srinivas TR, Meier-Kriesche HU. Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result. Clin J Am Soc Nephrol. 2008;3 Suppl 2:S101-S116. [PMID: 18308998 DOI: 10.2215/cjn.03510807] [Cited by in Crossref: 103] [Cited by in F6Publishing: 107] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 550 |
Park J, Ju MK, Song JS, Huh KH, Kim MS, Kim YS. Effects of mycophenolic Acid on high glucose-induced fibronectin secretion and cellular reactive oxygen species in rat vascular smooth muscle cells. Transplant Proc 2008;40:467-9. [PMID: 18374104 DOI: 10.1016/j.transproceed.2008.01.015] [Reference Citation Analysis]
|
| 551 |
Ashton-Chess J, Giral M, Mengel M, Renaudin K, Foucher Y, Gwinner W, Braud C, Dugast E, Quillard T, Thebault P, Chiffoleau E, Braudeau C, Charreau B, Soulillou JP, Brouard S. Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection. J Am Soc Nephrol 2008;19:1116-27. [PMID: 18369086 DOI: 10.1681/ASN.2007101056] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 552 |
Hamdy AF, Bakr MA, Ghoneim MA. Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients. J Am Soc Nephrol. 2008;19:1225-1232. [PMID: 18337483 DOI: 10.1681/asn.2007091001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 553 |
Chin GK, Adams CL, Carey BS, Shaw S, Tse WY, Kaminski ER. The value of serum neopterin, interferon-gamma levels and interleukin-12B polymorphisms in predicting acute renal allograft rejection. Clin Exp Immunol 2008;152:239-44. [PMID: 18341612 DOI: 10.1111/j.1365-2249.2008.03632.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 554 |
van Timmeren MM, Vaidya VS, van Ree RM, Oterdoom LH, de Vries AP, Gans RO, van Goor H, Stegeman CA, Bonventre JV, Bakker SJ. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation. 2007;84:1625-1630. [PMID: 18165774 DOI: 10.1097/01.tp.0000295982.78039.ef] [Cited by in Crossref: 133] [Cited by in F6Publishing: 122] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 555 |
Contreras AG, Briscoe DM. Every allograft needs a silver lining. J Clin Invest 2007;117:3645-8. [PMID: 18060023 DOI: 10.1172/JCI34238] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 556 |
Taylor AT. Kidney. Clinical Nuclear Medicine. [DOI: 10.1007/978-3-540-28026-2_7] [Reference Citation Analysis]
|
| 557 |
Legendre C, Zuber J, Anglicheau D, Le Quintrec M, Martinez F, Mamzer-bruneel M, Thervet E. Immunosuppression en transplantation rénale. EMC - Urologie 2008;1:1-7. [DOI: 10.1016/s1762-0953(06)75009-9] [Reference Citation Analysis]
|
| 558 |
Colvin RB, Mauiyyedi S. Pathology of Kidney Transplantation. Kidney Transplantation 2008. [DOI: 10.1016/b978-1-4160-3343-1.50028-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 559 |
Kunzendorf U, Ziegler E. Transplantation. Facharzt Nephrologie 2008. [DOI: 10.1016/b978-3-437-23900-7.50016-x] [Reference Citation Analysis]
|
| 560 |
Markowitz GS. Oral sodium phosphate bowel purgatives and acute phosphate nephropathy. Clinical Nephrotoxins 2008. [DOI: 10.1007/978-0-387-84843-3_26] [Reference Citation Analysis]
|
| 561 |
Knechtle SJ, Pirsch JD. Early Course of the Patient with a Kidney Transplant. Kidney Transplantation 2008. [DOI: 10.1016/b978-1-4160-3343-1.50018-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 562 |
Nankivell BJ. Chronic Allograft Nephropathy. Kidney Transplantation 2008. [DOI: 10.1016/b978-1-4160-3343-1.50029-3] [Reference Citation Analysis]
|
| 563 |
Basu A, Shapiro R. Tacrolimus in Renal Transplantation. Kidney Transplantation 2008. [DOI: 10.1016/b978-1-4160-3343-1.50021-9] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 564 |
Knechtle SJ. Kidney Transplantation. Surgery 2008. [DOI: 10.1007/978-0-387-68113-9_84] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 565 |
Webb NJ, Maxwell H. Chronic Renal Transplant Dysfunction. Comprehensive Pediatric Nephrology 2008. [DOI: 10.1016/b978-0-323-04883-5.50067-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 566 |
Krishnamurthi V. Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation. Yearbook of Urology 2008;2008:42-44. [DOI: 10.1016/s0084-4071(08)79108-5] [Reference Citation Analysis]
|
| 567 |
Krishnamurthi V. Mycophenolate mofetil is associated with altered expression of chronic renal transplant histology. Yearbook of Urology 2008;2008:41-42. [DOI: 10.1016/s0084-4071(08)79107-3] [Reference Citation Analysis]
|
| 568 |
Zhang PL, Rothblum LI, Han WK, Blasick TM, Potdar S, Bonventre JV. Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int 2008;73:608-14. [PMID: 18160964 DOI: 10.1038/sj.ki.5002697] [Cited by in Crossref: 135] [Cited by in F6Publishing: 140] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 569 |
Brouard S, Mansfield E, Braud C, Li L, Giral M, Hsieh SC, Baeten D, Zhang M, Ashton-Chess J, Braudeau C. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA. 2007;104:15448-15453. [PMID: 17873064 DOI: 10.1073/pnas.0705834104] [Cited by in Crossref: 289] [Cited by in F6Publishing: 300] [Article Influence: 18.1] [Reference Citation Analysis]
|
| 570 |
Mas VR, Mas LA, Archer KJ, Yanek K, King AL, Gibney EM, Cotterell A, Fisher RA, Posner M, Maluf DG. Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function. Mol Med 2007;13:315-24. [PMID: 17622313 DOI: 10.2119/2007–00017.Mas] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 571 |
Kingsley CI, Nadig SN, Wood KJ. Transplantation tolerance: lessons from experimental rodent models. Transpl Int 2007;20:828-41. [PMID: 17711408 DOI: 10.1111/j.1432-2277.2007.00533.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 572 |
Bunnapradist S, Danovitch GM. Minimizing ciclosporin in renal transplant recipients on daclizumab, mycophenolate and steroids. Nat Rev Nephrol 2007;3:426-427. [DOI: 10.1038/ncpneph0540] [Reference Citation Analysis]
|
| 573 |
Mas VR, Mas LA, Archer KJ, Yanek K, King AL, Gibney EM, Cotterell A, Fisher RA, Posner M, Maluf DG. Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function. Mol Med 2007;13:315-24. [PMID: 17622313 DOI: 10.2119/2007–00017.Mas] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 574 |
Kuypers DR. Kidney transplantation: current issues and future prospects. Acta Clin Belg 2007;62:208-17. [PMID: 17849691 DOI: 10.1179/acb.2007.034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 575 |
Pescovitz MD, Vincenti F, Hart M, Melton L, Whelchel J, Mulgaonkar S, McKay D, Leung M, Calleja E, Bouw MR. Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients. Br J Clin Pharmacol. 2007;64:758-771. [PMID: 17555465 DOI: 10.1111/j.1365-2125.2007.02934.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 576 |
Saint-Marcoux F, Marquet P, Jacqz-Aigrain E, Bernard N, Thiry P, Le Meur Y, Rousseau A. Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients. Clin Pharmacokinet 2006;45:905-22. [PMID: 16928152 DOI: 10.2165/00003088-200645090-00003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 577 |
ACUTE REJECTION. Medical Complications of Kidney Transplantation 2007. [DOI: 10.3109/9780203089903-6] [Reference Citation Analysis]
|
| 578 |
CHRONIC ALLOGRAFT NEPHROPATHY. Medical Complications of Kidney Transplantation 2007. [DOI: 10.3109/9780203089903-7] [Reference Citation Analysis]
|
| 579 |
Renders L, Kunzendorf U. Immunsuppressive Medikamente in der Therapie nach Nierentransplantation. Nephrologe 2007;2:157-166. [DOI: 10.1007/s11560-007-0080-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 580 |
Basu A, Falcone JL, Tan HP, Hassan D, Dvorchik I, Bahri K, Thai N, Randhawa PS, Marcos A, Starzl TE, Shapiro R. Chronic allograft nephropathy score before sirolimus rescue predicts allograft function in renal transplant patients. Transplant Proc 2007;39:94-8. [PMID: 17275482 DOI: 10.1016/j.transproceed.2006.10.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 581 |
Burke GW, Ciancio G. Long-term outcomes of IL-2R antibody vs antithymocyte globulin for induction therapy in kidney transplantation. Nat Rev Nephrol 2007;3:134-135. [DOI: 10.1038/ncpneph0393] [Reference Citation Analysis]
|
| 582 |
Alexander SI, Fletcher JT, Nankivell B. Chronic allograft nephropathy in paediatric renal transplantation. Pediatr Nephrol 2007;22:17-23. [PMID: 16944214 DOI: 10.1007/s00467-006-0219-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 583 |
Schwarz C, Oberbauer R. Calcineurin inhibitor sparing in renal transplantation: . Current Opinion in Organ Transplantation 2006;11:632-6. [DOI: 10.1097/mot.0b013e328010c511] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 584 |
Chapman J. Scoring arteriolar hyalinosis in renal allograft biopsies: so important and yet so tricky. Nat Clin Pract Nephrol 2006;2:622-3. [PMID: 17066053 DOI: 10.1038/ncpneph0322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 585 |
Williams D, Haragsim L. Calcineurin nephrotoxicity. Adv Chronic Kidney Dis 2006;13:47-55. [PMID: 16412970 DOI: 10.1053/j.ackd.2005.11.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 586 |
Baluja P, Haragsim L, Laszik Z. Chronic allograft nephropathy. Adv Chronic Kidney Dis 2006;13:56-61. [PMID: 16412971 DOI: 10.1053/j.ackd.2005.11.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 587 |
Rush DN. Can urinary monokine induced by interferon-γ accurately predict acute renal allograft rejection? Nat Rev Nephrol 2005;1:10-11. [DOI: 10.1038/ncpneph0027] [Reference Citation Analysis]
|
| 588 |
Webster AC, Woodroffe RC, Taylor RS, Chapman JR, Craig JC. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ 2005;331:810. [PMID: 16157605 DOI: 10.1136/bmj.38569.471007.AE] [Cited by in Crossref: 419] [Cited by in F6Publishing: 428] [Article Influence: 23.3] [Reference Citation Analysis]
|
| 589 |
Vicente AMG, Solís SR, Castrejón AS, García VMP, Rubio MDPT, Marina SR, Romera MC. Scintigraphic diagnosis of infectious complications in renal failure patients undergoing hemodialysis, continuous ambulatory peritoneal dialysis or renal transplant. Braz arch biol technol 2005;48:97-108. [DOI: 10.1590/s1516-89132005000700015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 590 |
Shapiro R, Basu A, Tan H, Gray E, Kahn A, Randhawa P, Murase N, Zeevi A, Girnita A, Metes D, Ness R, Bass DC, Demetris AJ, Fung JJ, Marcos A, Starzl TE. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg 2005;200:505-15; quiz A59-61. [PMID: 15804464 DOI: 10.1016/j.jamcollsurg.2004.12.024] [Cited by in Crossref: 152] [Cited by in F6Publishing: 157] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 591 |
Ponticelli C. Guest editor's introduction. Transplantation 2005;79:S69-71. [PMID: 15880018 DOI: 10.1097/01.tp.0000162432.18763.26] [Reference Citation Analysis]
|
| 592 |
Avihingsanon Y, Ma N, Pavlakis M, Chon WJ, Uknis ME, Monaco AP, Ferran C, Stillman I, Schachter AD, Mottley C, Zheng XX, Strom TB. On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. J Am Soc Nephrol 2005;16:1542-8. [PMID: 15888558 DOI: 10.1681/ASN.2005020210] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 593 |
Hernndez-fuentes M, Garn-ferreira M, Snchez-fueyo A. Sistema inmune y trasplante de ?rganos. Mecanismos de rechazo. Implicaciones cl?nicas. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 2005;9:2249-2259. [DOI: 10.1016/s0211-3449(05)73710-3] [Reference Citation Analysis]
|
| 594 |
Flechner SM, Lanigan CM, Salomon DR, Burke JT, Solez K. Response to: De Novo Kidney Transplantation Without Use of Calcineurin Inhibitors Preserves Renal Structure and Function at 2 Years. Am J Transplant 2005;5:1169-1169. [DOI: 10.1111/j.1600-6143.2005.00848.x] [Reference Citation Analysis]
|
| 595 |
Mourad G, Garrigue V, Bismuth J, Szwarc I, Delmas S, Iborra F. Suivi et complications non immunologiques de la transplantation rénale. EMC - Néphrologie 2005;2:61-82. [DOI: 10.1016/j.emcnep.2005.04.002] [Reference Citation Analysis]
|
| 596 |
Garwood S. Renal Function Update. Advances in Anesthesia 2005;23:41-54. [DOI: 10.1016/j.aan.2005.06.003] [Reference Citation Analysis]
|
| 597 |
Matas AJ, Kandaswamy R, Humar A, Payne WD, Dunn DL, Najarian JS, Gruessner RW, Gillingham KJ, McHugh LE, Sutherland DE. Long-term immunosuppression, without maintenance prednisone, after kidney transplantation. Ann Surg 2004;240:510-6; discussion 516-7. [PMID: 15319722 DOI: 10.1097/01.sla.0000137140.79206.d0] [Cited by in Crossref: 76] [Cited by in F6Publishing: 83] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 598 |
Jankowska-gan E, Burlingham WJ. Analysis of tolerance in human and nonhuman primates using delayed-type hypersensitivity: . Current Opinion in Organ Transplantation 2004;9:233-40. [DOI: 10.1097/01.mot.0000130145.14353.e5] [Reference Citation Analysis]
|
| 599 |
Drukker A. Renal transplantation and long-term graft survival for all children and adolescents with end-stage renal failure. Pediatr Transplant 2004;8:313-6. [PMID: 15265153 DOI: 10.1111/j.1399-3046.2004.00200.x] [Reference Citation Analysis]
|
| 600 |
Benediktsson H. Histopathology of chronic renal allograft dysfunction. Transplantation Reviews 2004;18:80-5. [DOI: 10.1016/j.trre.2004.03.005] [Reference Citation Analysis]
|
| 601 |
Joosten SA, Sijpkens YW, van Kooten C, Paul LC. Chronic rejection in renal transplantation. Transplantation Reviews 2004;18:86-95. [DOI: 10.1016/j.trre.2004.03.004] [Reference Citation Analysis]
|
